NF-kappaB	B-protein
activation	O
is	O
a	O
critical	O
regulator	O
of	O
human	O
granulocyte	O
apoptosis	O
in	O
vitro	O
.	O

During	O
beneficial	O
inflammation	O
,	O
potentially	O
tissue-damaging	B-cell_type
granulocytes	I-cell_type
undergo	O
apoptosis	O
before	O
being	O
cleared	O
by	O
phagocytes	O
in	O
a	O
non-phlogistic	O
manner	O
.	O

Here	O
we	O
show	O
that	O
the	O
rate	O
of	O
constitutive	O
apoptosis	O
in	O
human	B-cell_type
neutrophils	I-cell_type
and	O
eosinophils	B-cell_type
is	O
greatly	O
accelerated	O
in	O
both	O
a	O
rapid	O
and	O
concentration-dependent	O
manner	O
by	O
the	O
fungal	O
metabolite	O
gliotoxin	O
,	O
but	O
not	O
by	O
its	O
inactive	O
analog	O
methylthiogliotoxin	O
.	O

This	O
induction	O
of	O
apoptosis	O
was	O
abolished	O
by	O
the	O
caspase	O
inhibitor	O
zVAD-fmk	O
,	O
correlated	O
with	O
the	O
inhibition	O
of	O
nuclear	B-protein
factor-kappa	I-protein
B	I-protein
(	O
NF-kappaB	B-protein
)	O
,	O
and	O
was	O
mimicked	O
by	O
a	O
cell	O
permeable	O
inhibitory	O
peptide	O
of	O
NF-kappaB	B-protein
,	O
SN-50	O
;	O
other	O
NF-kappaB	B-protein
inhibitors	O
,	O
curcumin	O
and	O
pyrrolidine	O
dithiocarbamate	O
;	O
and	O
the	O
proteasome	O
inhibitor	O
,	O
MG-132	O
.	O

Gliotoxin	O
also	O
augmented	O
dramatically	O
the	O
early	O
(	O
2-6	O
h	O
)	O
pro-apoptotic	O
effects	O
of	O
tumor	B-protein
necrosis	I-protein
factor-alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
in	O
neutrophils	B-cell_type
and	O
unmasked	O
the	O
ability	O
of	O
TNF-alpha	B-protein
to	O
induce	O
eosinophil	B-cell_type
apoptosis	O
.	O

In	O
neutrophils	B-cell_type
,	O
TNF-alpha	B-protein
caused	O
a	O
gliotoxin-inhibitable	O
activation	O
of	O
an	O
inducible	O
form	O
of	O
NF-kappaB	B-protein
,	O
a	O
response	O
that	O
may	O
underlie	O
the	O
ability	O
of	O
TNF-alpha	B-protein
to	O
delay	O
apoptosis	O
at	O
later	O
times	O
(	O
12-24	O
h	O
)	O
and	O
limit	O
its	O
early	O
killing	O
effect	O
.	O

Furthermore	O
,	O
cycloheximide	O
displayed	O
a	O
similar	O
capacity	O
to	O
enhance	O
TNF-alpha	B-protein
induced	O
neutrophil	O
apoptosis	O
even	O
at	O
time	O
points	O
when	O
cycloheximide	O
alone	O
had	O
no	O
pro-apoptotic	O
effect	O
,	O
suggesting	O
that	O
NF-kappaB	B-protein
may	O
regulate	O
the	O
production	O
of	O
protein	O
(	O
s	O
)	O
which	O
protect	O
neutrophils	B-cell_type
from	O
the	O
cytotoxic	O
effects	O
of	O
TNF-alpha	B-protein
.	O

These	O
data	O
shed	O
light	O
on	O
the	O
biochemical	O
and	O
molecular	O
mechanisms	O
regulating	O
human	O
granulocyte	O
apoptosis	O
and	O
,	O
in	O
particular	O
,	O
indicate	O
that	O
the	O
transcription	B-protein
factor	I-protein
NF-kappaB	B-protein
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
the	O
physiological	O
cell	O
death	O
pathway	O
in	O
granulocytes	B-cell_type
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

7	NULL
,	NULL
Issue	NULL
of	NULL
February	NULL
12	NULL
,	NULL
pp	NULL
.	NULL

4309-4318	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
NF-rB	NULL
Activation	NULL
Is	NULL
a	NULL
Critical	NULL
Regulator	NULL
of	NULL
Human	NULL
Granulocyte	NULL
Apoptosis	NULL
in	NULL
Vitro*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
19	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
October	NULL
12	NULL
,	NULL
1998	NULL
)	NULL
Carol	NULL
Wardt	NULL
,	NULL
Edwin	NULL
R.	NULL
Chilvers	NULL
$	NULL
§	NULL
,	NULL
Mark	NULL
F.	NULL
Lawson	NULL
,	NULL
James	NULL
G.	NULL
Pryde	NULL
,	NULL
Satoko	NULL
Fujihara	NULL
,	NULL
Stuart	NULL
N.	NULL
Farrow1	NULL
,	NULL
Christopher	NULL
Haslett	NULL
,	NULL
and	NULL
Adriano	NULL
G.	NULL
Rossi	NULL
]	NULL
From	NULL
the	NULL
Respiratory	NULL
Medicine	NULL
Unit	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
(	NULL
RIE	NULL
)	NULL
,	NULL
Rayne	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Edinburgh	NULL
Medical	NULL
School	NULL
,	NULL
Teviot	NULL
Place	NULL
,	NULL
Edinburgh	NULL
,	NULL
EHS	NULL
9AG	NULL
,	NULL
United	NULL
Kingdom	NULL
and	NULL
The	NULL
Cell	NULL
Biology	NULL
Unit	NULL
,	NULL
Glaxo-Wellcome	NULL
,	NULL
Gunnelswood	NULL
Road	NULL
,	NULL
Stevenage	NULL
,	NULL
Herts	NULL
,	NULL
SG1	NULL
2NY	NULL
,	NULL
United	NULL
Kingdom	NULL
During	NULL
beneficial	NULL
inflammation	NULL
,	NULL
potentially	NULL
tissue-damaging	NULL
granulocytes	NULL
undergo	NULL
apoptosis	NULL
before	NULL
being	NULL
cleared	NULL
by	NULL
phagocytes	NULL
in	NULL
a	NULL
non-phlogistic	NULL
manner	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
the	NULL
rate	NULL
of	NULL
constitutive	NULL
apoptosis	NULL
in	NULL
human	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
is	NULL
greatly	NULL
accelerated	NULL
in	NULL
both	NULL
a	NULL
rapid	NULL
and	NULL
concentration-dependent	NULL
manner	NULL
by	NULL
the	NULL
fungal	NULL
metabolite	NULL
gliotoxin	NULL
,	NULL
but	NULL
not	NULL
by	NULL
its	NULL
inactive	NULL
analog	NULL
methylthiogliotoxin	NULL
.	NULL

This	NULL
induction	NULL
of	NULL
apoptosis	NULL
was	NULL
abolished	NULL
by	NULL
the	NULL
caspase	NULL
inhibitor	NULL
zVAD-fmk	NULL
,	NULL
correlated	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
and	NULL
was	NULL
mimicked	NULL
by	NULL
a	NULL
cell	NULL
permeable	NULL
inhibitory	NULL
peptide	NULL
of	NULL
NF-xB	NULL
,	NULL
SN-50	NULL
;	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
,	NULL
curcumin	NULL
and	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
and	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
MG-132	NULL
.	NULL

Gliotoxin	NULL
also	NULL
augmented	NULL
dramatically	NULL
the	NULL
early	NULL
(	NULL
2-6	NULL
h	NULL
)	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
LNF-a	NULL
)	NULL
in	NULL
neutrophils	NULL
and	NULL
unmasked	NULL
the	NULL
ability	NULL
of	NULL
TNF-a	NULL
«	NULL
to	NULL
induce	NULL
eosinophil	NULL
apoptosis	NULL
.	NULL

In	NULL
neutrophils	NULL
,	NULL
TNF-a	NULL
caused	NULL
a	NULL
gliotoxin-inhibit-able	NULL
activation	NULL
of	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
NF-KB	NULL
,	NULL
a	NULL
response	NULL
that	NULL
may	NULL
underlie	NULL
the	NULL
ability	NULL
of	NULL
TNF-a	NULL
to	NULL
delay	NULL
apoptosis	NULL
at	NULL
later	NULL
times	NULL
(	NULL
12-24	NULL
h	NULL
)	NULL
and	NULL
limit	NULL
its	NULL
early	NULL
killing	NULL
effect	NULL
.	NULL

Furthermore	NULL
,	NULL
cycloheximide	NULL
displayed	NULL
a	NULL
similar	NULL
capacity	NULL
to	NULL
enhance	NULL
TNF-a	NULL
induced	NULL
neutrophil	NULL
apoptosis	NULL
even	NULL
at	NULL
time	NULL
points	NULL
when	NULL
cycloheximide	NULL
alone	NULL
had	NULL
no	NULL
pro-apoptotic	NULL
effect	NULL
,	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
may	NULL
regulate	NULL
the	NULL
production	NULL
of	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
which	NULL
protect	NULL
neutrophils	NULL
from	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-a	NULL
.	NULL

These	NULL
data	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
biochemical	NULL
and	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
human	NULL
granulocyte	NULL
apoptosis	NULL
and	NULL
,	NULL
in	NULL
particular	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
physiological	NULL
cell	NULL
death	NULL
pathway	NULL
in	NULL
granulocytes	NULL
.	NULL

Neutrophilic	NULL
and	NULL
eosinophilic	NULL
granulocytes	NULL
originate	NULL
from	NULL
a	NULL
common	NULL
myeloid	NULL
precursor	NULL
;	NULL
neutrophils	NULL
are	NULL
particularly	NULL
active	NULL
in	NULL
the	NULL
defense	NULL
against	NULL
invading	NULL
micro-organisms	NULL
whereas	NULL
eosinophils	NULL
serve	NULL
in	NULL
anti-parasitic	NULL
defenses	NULL
and	NULL
play	NULL
a	NULL
role	NULL
in	NULL
allergic	NULL
inflammation	NULL
.	NULL

The	NULL
normally	NULL
beneficial	NULL
acute	NULL
inflammatory	NULL
response	NULL
can	NULL
become	NULL
dysregulated	NULL
and	NULL
result	NULL
in	NULL
chronic	NULL
inflammatory	NULL
conditions	NULL
where	NULL
tissue	NULL
damage	NULL
arises	NULL
in	NULL
part	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Medical	NULL
Research	NULL
Council	NULL
Program	NULL
Grant	NULL
G9016491	NULL
and	NULL
the	NULL
Wellcome	NULL
Trust	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7	NULL
Supported	NULL
by	NULL
a	NULL
Glaxo-Wellcome	NULL
studentship	NULL
.	NULL

§	NULL
Wellcome	NULL
Senior	NULL
Research	NULL
Fellow	NULL
in	NULL
Clinical	NULL
Science	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Respiratory	NULL
Medicine	NULL
Unit	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Medicine	NULL
,	NULL
Rayne	NULL
Laboratory	NULL
,	NULL
University	NULL
of	NULL
Edinburgh	NULL
Medical	NULL
School	NULL
,	NULL
Teviot	NULL
Place	NULL
,	NULL
Edinburgh	NULL
,	NULL
EH8	NULL
9AG	NULL
,	NULL
Scotland	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
44-181-651-1823	NULL
;	NULL
Fax	NULL
:	NULL
44-181-650-4884	NULL
;	NULL
E-mail	NULL
:	NULL
a.g.rossi	NULL
@	NULL
ed.ac.uk	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
due	NULL
to	NULL
the	NULL
inappropriate	NULL
liberation	NULL
of	NULL
inflammatory	NULL
cell-de-rived	NULL
histotoxic	NULL
products	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
described	NULL
a	NULL
granulocyte	NULL
clearance	NULL
mechanism	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
normal	NULL
control	NULL
and	NULL
resolution	NULL
processes	NULL
of	NULL
inflammation	NULL
whereby	NULL
granulocytes	NULL
must	NULL
first	NULL
undergo	NULL
apoptosis	NULL
(	NULL
pro-grammed	NULL
cell	NULL
death	NULL
)	NULL
before	NULL
being	NULL
phagocytosed	NULL
and	NULL
cleared	NULL
by	NULL
macrophages	NULL
in	NULL
sifu	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Apoptosis	NULL
also	NULL
causes	NULL
functional	NULL
down-regulation	NULL
of	NULL
granulocytes	NULL
and	NULL
the	NULL
retention	NULL
of	NULL
proteolytic	NULL
granule	NULL
contents	NULL
to	NULL
further	NULL
limit	NULL
the	NULL
potential	NULL
for	NULL
granu-locyte-mediated	NULL
tissue	NULL
damage	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

While	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
physiological	NULL
mechanisms	NULL
involved	NULL
in	NULL
controlling	NULL
granulocyte	NULL
apoptosis	NULL
,	NULL
many	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
now	NULL
shown	NULL
that	NULL
an	NULL
array	NULL
of	NULL
pro-inflammatory	NULL
cytokines	NULL
and	NULL
inflammatory	NULL
mediators	NULL
known	NULL
to	NULL
be	NULL
present	NULL
at	NULL
inflamed	NULL
sites	NULL
inhibit	NULL
the	NULL
process	NULL
of	NULL
apoptosis	NULL
in	NULL
granulocytes	NULL
(	NULL
2-9	NULL
)	NULL
.	NULL

This	NULL
has	NULL
led	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
such	NULL
agents	NULL
act	NULL
both	NULL
to	NULL
attract	NULL
and	NULL
activate	NULL
inflammatory	NULL
cells	NULL
and	NULL
also	NULL
delay	NULL
their	NULL
removal	NULL
.	NULL

A	NULL
notable	NULL
exception	NULL
to	NULL
this	NULL
rule	NULL
,	NULL
however	NULL
,	NULL
is	NULL
TNF-a	NULL
,	NULL
which	NULL
,	NULL
at	NULL
early	NULL
time	NULL
points	NULL
in	NULL
neutrophil	NULL
culture	NULL
,	NULL
causes	NULL
acceleration	NULL
of	NULL
the	NULL
constitutive	NULL
rate	NULL
of	NULL
apoptosis	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Many	NULL
inflammatory	NULL
mediators	NULL
regulate	NULL
gene	NULL
expression	NULL
in	NULL
target	NULL
cells	NULL
by	NULL
influencing	NULL
the	NULL
activities	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
(	NULL
NF-kB	NULL
)	NULL
.	NULL

NF-kB	NULL
is	NULL
composed	NULL
of	NULL
homo-or	NULL
heterodimers	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
proteins	NULL
(	NULL
p5O/NFxB1	NULL
,	NULL
p5¥/	NULL
NFxB2	NULL
,	NULL
p65/ReIA	NULL
,	NULL
and	NULL
cRel	NULL
)	NULL
which	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
physical	NULL
association	NULL
with	NULL
inhibitor	NULL
proteins	NULL
referred	NULL
to	NULL
as	NULL
IB	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Upon	NULL
activation	NULL
,	NULL
the	NULL
IB	NULL
subunit	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
leading	NULL
to	NULL
its	NULL
proteolytic	NULL
breakdown	NULL
permitting	NULL
NF-B	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
where	NULL
it	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
many	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
inflammatory	NULL
re-sponse	NULL
,	NULL
including	NULL
those	NULL
for	NULL
pro-inflammatory	NULL
cytokines	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
systems	NULL
TNF-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
rapid	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
response	NULL
known	NULL
to	NULL
mediate	NULL
a	NULL
number	NULL
of	NULL
TNF	NULL
induced	NULL
cellular	NULL
responses	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

14-16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
whether	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
involved	NULL
in	NULL
either	NULL
the	NULL
pro-	NULL
or	NULL
anti-apoptotic	NULL
effects	NULL
of	NULL
TNF-a	NULL
@	NULL
in	NULL
granulocytes	NULL
is	NULL
currently	NULL
unknown	NULL
.	NULL

Whereas	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
,	NULL
a	NULL
completely	NULL
opposite	NULL
effect	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
where	NULL
apoptosis	NULL
is	NULL
associated	NULL
with	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
reported	NULL
that	NULL
inactivation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
increases	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-a	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

In	NULL
granulocytes	NULL
,	NULL
it	NULL
remains	NULL
uncertain	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
inflammatory	NULL
mediators	NULL
,	NULL
or	NULL
is	NULL
indeed	NULL
present	NULL
,	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

For	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
NF-KB	NULL
,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
;	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
;	NULL
zVAD-fmk	NULL
,	NULL
ben-zyloxycarbonyl-Val-Ala-Asp-fluoromethylketone	NULL
:	NULL
DMEM	NULL
,	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
.	NULL

4309	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
4310	NULL
example	NULL
,	NULL
while	NULL
MacDonald	NULL
et	NULL
al	NULL
.	NULL

,	NULL
(	NULL
22	NULL
)	NULL
reported	NULL
that	NULL
lipopo-lysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
the	NULL
chemotactic	NULL
peptide	NULL
N-formyl-methionyl-leucyl-phenylalanine	NULL
all	NULL
cause	NULL
a	NULL
marked	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
Browning	NULL
et	NULL
al	NULL
.	NULL

,	NULL
(	NULL
23	NULL
)	NULL
found	NULL
no	NULL
such	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
despite	NULL
obvious	NULL
NF-KB	NULL
activation	NULL
in	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Gliotoxin	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
epipolythiodioxoperazine	NULL
family	NULL
of	NULL
compounds	NULL
(	NULL
24	NULL
)	NULL
,	NULL
exhibits	NULL
immunosuppressive	NULL
activity	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

For	NULL
example	NULL
,	NULL
gliotoxin	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
mitogen-induced	NULL
proliferation	NULL
of	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
induce	NULL
macrophage	NULL
and	NULL
osteoclast	NULL
apoptosis	NULL
in	NULL
vitro	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
and	NULL
cause	NULL
thymocyte	NULL
and	NULL
spleen	NULL
cell	NULL
apoptosis	NULL
in	NULL
vivo	NULL
(	NULL
27	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biochemical	NULL
and	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
these	NULL
effects	NULL
remain	NULL
uncertain	NULL
.	NULL

Gliotoxin	NULL
has	NULL
,	NULL
however	NULL
,	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
and	NULL
specific	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
28	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
gliotoxin	NULL
as	NULL
a	NULL
pharmacological	NULL
tool	NULL
to	NULL
investigate	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
granulocyte	NULL
apoptosis	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
gliotoxin	NULL
causes	NULL
a	NULL
rapid	NULL
and	NULL
major	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
in	NULL
vitro	NULL
and	NULL
up-regulates	NULL
TNF-o-induced	NULL
apoptosis	NULL
in	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
these	NULL
effects	NULL
occur	NULL
via	NULL
a	NULL
specific	NULL
,	NULL
nontoxic	NULL
and	NULL
caspase-controlled	NULL
mechanism	NULL
that	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
gliotoxin	NULL
to	NULL
inhibit	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
to	NULL
cause	NULL
a	NULL
similar	NULL
induction	NULL
of	NULL
apoptosis	NULL
provides	NULL
further	NULL
evidence	NULL
supporting	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
granulocyte	NULL
apoptosis	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
TNF-a	NULL
is	NULL
enhanced	NULL
by	NULL
protein	NULL
synthesis	NULL
blockade	NULL
suggesting	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
results	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
unidentified	NULL
survival	NULL
protein	NULL
.	NULL

These	NULL
data	NULL
therefore	NULL
strongly	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
regulating	NULL
both	NULL
constitutive	NULL
and	NULL
TNF-	NULL
@	NULL
stimulated	NULL
human	NULL
granulocyte	NULL
apoptosis	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Neutrophil	NULL
and	NULL
Eosinophil	NULL
Isolation	NULL
and	NULL
Culture	NULL
Neutrophils	NULL
and	NULL
eosinophils	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
donors	NULL
by	NULL
dextran	NULL
sedimentation	NULL
followed	NULL
by	NULL
centrifugation	NULL
through	NULL
discontinuous	NULL
plasma-Percoll	NULL
gradients	NULL
(	NULL
2	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Only	NULL
neutrophil	NULL
preparations	NULL
with	NULL
a	NULL
neutrophil	NULL
purity	NULL
of	NULL
>	NULL
98	NULL
%	NULL
were	NULL
used	NULL
.	NULL

Eosinophils	NULL
were	NULL
separated	NULL
from	NULL
contaminating	NULL
neutrophils	NULL
using	NULL
an	NULL
immu-nomagnetic	NULL
separation	NULL
step	NULL
with	NULL
sheep	NULL
anti-mouse	NULL
IgG-Dynabeads	NULL
(	NULL
Dynabeads	NULL
M-450	NULL
,	NULL
Dynal	NULL
,	NULL
Merseyside	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
coated	NULL
with	NULL
the	NULL
murine	NULL
anti-neutrophil	NULL
antibody	NULL
3G8	NULL
(	NULL
anti-CD16	NULL
;	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
J.	NULL
Unkeless	NULL
,	NULL
Mount	NULL
Sinai	NULL
Medical	NULL
School	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
mixed	NULL
with	NULL
washed	NULL
3GB-coated	NULL
Dynabeads	NULL
at	NULL
a	NULL
bead	NULL
:	NULL
neutrophil	NULL
ratio	NULL
of	NULL
3:1	NULL
on	NULL
a	NULL
rotary	NULL
mixer	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
the	NULL
beads	NULL
removed	NULL
magnetically	NULL
by	NULL
two	NULL
3-min	NULL
stationary	NULL
magnetic	NULL
contacts	NULL
(	NULL
Dynal	NULL
Magnetic	NULL
Particle	NULL
Concentrator	NULL
,	NULL
MPC-1	NULL
)	NULL
to	NULL
yield	NULL
an	NULL
a	NULL
eosinophil	NULL
population	NULL
of	NULL
>	NULL
98	NULL
%	NULL
purity	NULL
.	NULL

After	NULL
purification	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
without	NULL
calcium	NULL
and	NULL
magnesium	NULL
and	NULL
once	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
before	NULL
resuspending	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
(	NULL
Life	NULL
Technolo-gies	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
with	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
.	NULL

Both	NULL
cell	NULL
types	NULL
were	NULL
cultured	NULL
in	NULL
flat-bottomed	NULL
Falcon	NULL
flexible	NULL
wells	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Ox-ford	NULL
,	NULL
UK	NULL
)	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
atmosphere	NULL
;	NULL
neutrophils	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
5	NULL
X	NULL
10°/ml	NULL
and	NULL
eosinophils	NULL
at	NULL
2	NULL
X	NULL
10®/ml	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
test	NULL
agents	NULL
as	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
3	NULL
times	NULL
and	NULL
each	NULL
treatment	NULL
done	NULL
in	NULL
triplicate	NULL
.	NULL

Assessment	NULL
of	NULL
Granulocyte	NULL
Apoptosis	NULL
Morphology-Cells	NULL
were	NULL
cyto-centrifuged	NULL
,	NULL
fixed	NULL
in	NULL
methanol	NULL
,	NULL
stained	NULL
with	NULL
Diff-Quik®*	NULL
,	NULL
and	NULL
counted	NULL
using	NULL
oil	NULL
immersion	NULL
microscopy	NULL
(	NULL
X100	NULL
objective	NULL
)	NULL
to	NULL
determine	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
with	NULL
highly	NULL
distinctive	NULL
apoptotic	NULL
morphology	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
10	NULL
)	NULL
.	NULL

At	NULL
least	NULL
500	NULL
cells	NULL
were	NULL
counted	NULL
per	NULL
slide	NULL
with	NULL
the	NULL
observer	NULL
blinded	NULL
to	NULL
the	NULL
experiment	NULL
conditions	NULL
.	NULL

The	NULL
results	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
%	NULL
apoptosis	NULL
+	NULL
S.E	NULL
.	NULL

Annexin	NULL
V	NULL
Binding-A	NULL
separate	NULL
and	NULL
independent	NULL
assessment	NULL
of	NULL
apoptosis	NULL
was	NULL
performed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
fluorescein	NULL
isothiocyanate-labeled	NULL
recombinant	NULL
human	NULL
annexin	NULL
V	NULL
that	NULL
binds	NULL
to	NULL
phosphatidylserine	NULL
exposed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
apoptotic	NULL
cells	NULL
.	NULL

Stock	NULL
annexin	NULL
V	NULL
(	NULL
Bender	NULL
MedSystems	NULL
,	NULL
Vienna	NULL
,	NULL
Austria	NULL
)	NULL
was	NULL
diluted	NULL
1:200	NULL
with	NULL
binding	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
buffer	NULL
and	NULL
then	NULL
added	NULL
(	NULL
25	NULL
pl	NULL
)	NULL
to	NULL
75	NULL
pl	NULL
of	NULL
the	NULL
recovered	NULL
cell	NULL
samples	NULL
.	NULL

Following	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
these	NULL
samples	NULL
were	NULL
fixed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
100	NULL
ul	NULL
of	NULL
8	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
before	NULL
analysis	NULL
using	NULL
an	NULL
EPICS	NULL
Profile	NULL
II	NULL
(	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Luton	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

DNA	NULL
Fragmentation	NULL
Assay-DNA	NULL
was	NULL
extracted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
neutrophils	NULL
were	NULL
taken	NULL
after	NULL
the	NULL
indicated	NULL
treatment	NULL
and	NULL
lysed	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
6	NULL
M	NULL
guanidine	NULL
hydrochlo-ride	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
N-lauroyl	NULL
sarcosine	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
and	NULL
the	NULL
nucleic	NULL
acids	NULL
extracted	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.0-saturated	NULL
phenol	NULL
:	NULL
chloroform	NULL
mixture	NULL
(	NULL
50:50	NULL
,	NULL
v/v	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
emulsion	NULL
was	NULL
centrifuged	NULL
at	NULL
12,000	NULL
*	NULL
g	NULL
,	NULL
,	NULL
,	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
the	NULL
aqueous	NULL
phase	NULL
removed	NULL
and	NULL
precipitated	NULL
with	NULL
0.6	NULL
volumes	NULL
of	NULL
isopropyl	NULL
alcohol	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
precipitated	NULL
nucleic	NULL
acids	NULL
were	NULL
then	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
X	NULL
g	NULL
,	NULL
,	NULL
for	NULL
5	NULL
min	NULL
and	NULL
re-dissolved	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
TE	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
pH	NULL
8.0	NULL
)	NULL
containing	NULL
50	NULL
ug/ml	NULL
RNase	NULL
A	NULL
.	NULL

The	NULL
fragmented	NULL
DNA	NULL
was	NULL
separated	NULL
by	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
on	NULL
a	NULL
1.4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
agarose	NULL
(	NULL
Flowgen	NULL
,	NULL
UK	NULL
)	NULL
0.5	NULL
x	NULL
TBE	NULL
(	NULL
10	NULL
mM	NULL
Trizma	NULL
(	NULL
Tris	NULL
base	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
boric	NULL
acid	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.3	NULL
)	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
run	NULL
for	NULL
2	NULL
h	NULL
at	NULL
75	NULL
V	NULL
and	NULL
stained	NULL
using	NULL
ethidium	NULL
bromide	NULL
(	NULL
0.5	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
UV	NULL
transilluminated	NULL
image	NULL
was	NULL
printed	NULL
by	NULL
digital	NULL
thermal	NULL
printing	NULL
using	NULL
a	NULL
GS7600	NULL
gel	NULL
documentation	NULL
system	NULL
(	NULL
UVP	NULL
Products	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Assessment	NULL
of	NULL
Cell	NULL
Membrane	NULL
Integrity	NULL
Since	NULL
apoptotic	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
maintain	NULL
the	NULL
integrity	NULL
of	NULL
their	NULL
plasma	NULL
membrane	NULL
,	NULL
assessment	NULL
of	NULL
granulocyte	NULL
necrosis	NULL
can	NULL
be	NULL
determined	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
cells	NULL
to	NULL
exclude	NULL
the	NULL
vital	NULL
dye	NULL
trypan	NULL
blue	NULL
and	NULL
also	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
propidium	NULL
iodide	NULL
staining	NULL
.	NULL

Samples	NULL
(	NULL
150	NULL
pl	NULL
of	NULL
cells	NULL
at	NULL
2	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
centrifuged	NULL
and	NULL
resuspended	NULL
in	NULL
150	NULL
ul	NULL
of	NULL
propidium	NULL
iodide	NULL
solution	NULL
(	NULL
83	NULL
ug/ml	NULL
propidium	NULL
iodide	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
containing	NULL
1.67	NULL
mg/ml	NULL
RNase	NULL
)	NULL
.	NULL

The	NULL
profiles	NULL
of	NULL
heat-treated	NULL
(	NULL
necrotic	NULL
cells	NULL
)	NULL
from	NULL
the	NULL
same	NULL
samples	NULL
were	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
EMSAs	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Promega	NULL
Corp	NULL
,	NULL
Southampton	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
80	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
pelleted	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
hypotonic	NULL
buffer	NULL
(	NULL
buffer	NULL
A	NULL
:	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
1.5	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
mM	NULL
KCl	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
,	NULL
1	NULL
uM	NULL
4-	NULL
(	NULL
2-aminoeth-yl	NULL
)	NULL
benzenesulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.5	NULL
mM	NULL
ben-zamidine	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
levamisole	NULL
)	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Following	NULL
the	NULL
addition	NULL
of	NULL
0.1	NULL
volumes	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
W/v	NULL
)	NULL
the	NULL
cells	NULL
were	NULL
vortexed	NULL
briefly	NULL
and	NULL
centrifuged	NULL
at	NULL
12,000	NULL
%	NULL
g	NULL
,	NULL
,	NULL
,	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
discarded	NULL
and	NULL
the	NULL
pellet	NULL
washed	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
buffer	NULL
A	NULL
minus	NULL
Nonidet	NULL
P-40	NULL
and	NULL
re-centrifuged	NULL
.	NULL

The	NULL
pelleted	NULL
nuclei	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
hypertonic	NULL
buffer	NULL
(	NULL
buffer	NULL
B	NULL
:	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
1.5	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
A	NULL
,	NULL
1	NULL
uM	NULL
4-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
ben-zenesulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.5	NULL
mM	NULL
benzami-dine	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
levamisole	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
until	NULL
use	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
approximately	NULL
2	NULL
ug	NULL
of	NULL
protein	NULL
,	NULL
7	NULL
X	NULL
10°	NULL
cell	NULL
equiv-alent	NULL
,	NULL
in	NULL
7	NULL
pl	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
binding	NULL
buffer	NULL
(	NULL
4	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
with	NULL
50	NULL
ug/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
UK	NULL
)	NULL
with	NULL
17	NULL
fmol	NULL
of	NULL
y-*°P-labeled	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
decameric	NULL
«	NULL
B-binding	NULL
site	NULL
(	NULL
3000	NULL
Ci/mmol	NULL
;	NULL
Promega	NULL
Corp.	NULL
,	NULL
Southampton	NULL
,	NULL
UK	NULL
)	NULL
at	NULL
22	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
5	NULL
ul	NULL
of	NULL
loading	NULL
buffer	NULL
(	NULL
0.01	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
bromphenol	NULL
blue	NULL
,	NULL
20	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
Ficoll	NULL
400	NULL
%	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
onto	NULL
an	NULL
8	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
native	NULL
acryl-amide	NULL
gel	NULL
(	NULL
Protean	NULL
IIxi	NULL
,	NULL
Bio-Rad	NULL
,	NULL
Hemel	NULL
Hempstead	NULL
,	NULL
UK	NULL
)	NULL
in	NULL
0.5	NULL
X	NULL
TBE	NULL
buffer	NULL
and	NULL
run	NULL
at	NULL
250	NULL
V	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
onto	NULL
3MM	NULL
paper	NULL
(	NULL
Whatman	NULL
UK	NULL
,	NULL
Maidstone	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
BioMax	NULL
MS-1	NULL
x-ray	NULL
film	NULL
(	NULL
Kodak	NULL
,	NULL
Anachem	NULL
,	NULL
Luton	NULL
,	NULL
UK	NULL
)	NULL
was	NULL
exposed	NULL
to	NULL
the	NULL
gel	NULL
.	NULL

Processed	NULL
films	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
Grablt	NULL
and	NULL
GelPlate	NULL
software	NULL
(	NULL
UVP	NULL
,	NULL
Orme	NULL
Technol-ogies	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
the	NULL
data	NULL
expressed	NULL
as	NULL
a	NULL
percent	NULL
of	NULL
the	NULL
control	NULL
value	NULL
for	NULL
each	NULL
experiment	NULL
.	NULL

Materials	NULL
Further	NULL
specific	NULL
materials	NULL
were	NULL
obtained	NULL
as	NULL
follows	NULL
:	NULL
curcumin	NULL
,	NULL
gliotoxin	NULL
,	NULL
LPS	NULL
(	NULL
Escherichia	NULL
coli	NULL
0127	NULL
:	NULL
B8	NULL
)	NULL
,	NULL
methylthiogliotoxin	NULL
,	NULL
and	NULL
PDTC	NULL
(	NULL
Sigma	NULL
Co.	NULL
,	NULL
Poole	NULL
,	NULL
UK	NULL
)	NULL
;	NULL
recombinant	NULL
human	NULL
TNF-	NULL
@	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Abingdon	NULL
,	NULL
Oxon	NULL
,	NULL
UK	NULL
)	NULL
;	NULL
zVAD-fmk	NULL
(	NULL
Bachem	NULL
(	NULL
UK	NULL
)	NULL
Ltd.	NULL
,	NULL
Saffron	NULL
Walden	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
proteasome	NULL
inhibitor	NULL
MG-182	NULL
(	NULL
N-cbz-Leu-Leu-leucinal	NULL
)	NULL
,	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitory	NULL
peptides	NULL
SN50	NULL
and	NULL
SN5OM	NULL
(	NULL
Biomol	NULL
,	NULL
Affinity	NULL
Re	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
100	NULL
so	NULL
--	NULL
2h	NULL
C	NULL
-BR-6h	NULL
8	NULL
so	NULL
-	NULL
@	NULL
-20	NULL
h	NULL
2	NULL
«	NULL
M	NULL
far	NULL
o	NULL
.	NULL

<	NULL
G	NULL
40	NULL
Es	NULL
20	NULL
0	NULL
&	NULL
=	NULL
--	NULL
@	NULL
--	NULL
#	NULL
e	NULL
0.001	NULL
0.01	NULL
01	NULL
1	NULL
10	NULL
Gliotoxin	NULL
(	NULL
ug/ml	NULL
)	NULL
[	NULL
Control	NULL
100	NULL
4	NULL
methylthiogliotoxin	NULL
(	NULL
301g/m	NULL
!	NULL
)	NULL

MGliotoxin	NULL
(	NULL
30	NULL
pg/im	NULL
!	NULL
)	NULL

%	NULL
Apoptosis	NULL
..	NULL
__KH	NULL
2	NULL
6	NULL
20	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Time	NULL
course	NULL
and	NULL
concentration-response	NULL
curve	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
gliotoxin	NULL
on	NULL
human	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
neutrophils	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
87	NULL
°C	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
gliotoxin	NULL
.	NULL

At	NULL
the	NULL
time	NULL
periods	NULL
indicated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparations	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

A	NULL
,	NULL
represents	NULL
the	NULL
effect	NULL
of	NULL
gliotoxin	NULL
(	NULL
0.001-30	NULL
pg/m1	NULL
)	NULL
on	NULL
neutrophil	NULL
apoptosis	NULL
after	NULL
2	NULL
,	NULL
6	NULL
,	NULL
or	NULL
20	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

B	NULL
,	NULL
represents	NULL
the	NULL
effect	NULL
of	NULL
methylthiogliotoxin	NULL
(	NULL
80	NULL
ug/ml	NULL
)	NULL
or	NULL
gliotoxin	NULL
(	NULL
80	NULL
pg/ml	NULL
)	NULL
on	NULL
neutrophil	NULL
apoptosis	NULL
after	NULL
2	NULL
,	NULL
6	NULL
,	NULL
or	NULL
20	NULL
h	NULL
culture	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

search	NULL
Products	NULL
,	NULL
Mamhead	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
,	NULL
UK	NULL
,	NULL
and	NULL
were	NULL
of	NULL
the	NULL
highest	NULL
purity	NULL
.	NULL

Statistical	NULL
Analysis	NULL
The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
the	NULL
number	NULL
(	NULL
n	NULL
)	NULL
of	NULL
independent	NULL
experiments	NULL
each	NULL
using	NULL
cells	NULL
from	NULL
separate	NULL
donors	NULL
with	NULL
each	NULL
treatment	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
ANOVA	NULL
with	NULL
comparisons	NULL
between	NULL
groups	NULL
made	NULL
using	NULL
the	NULL
Newman-Kuels	NULL
procedure	NULL
.	NULL

Differences	NULL
were	NULL
considered	NULL
significant	NULL
when	NULL
p	NULL
<	NULL
0.05	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
Gliotoxin	NULL
on	NULL
Neutrophil	NULL
Apoptosis-As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
gliotoxin	NULL
caused	NULL
a	NULL
rapid	NULL
and	NULL
profound	NULL
induction	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
in	NULL
vifro	NULL
which	NULL
was	NULL
both	NULL
concentration	NULL
(	NULL
e.g	NULL
.	NULL

at	NULL
6	NULL
h	NULL
EC	NULL
;	NULL
,	NULL
=	NULL
76.1	NULL
+	NULL
22.1	NULL
ng/ml	NULL
,	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
and	NULL
time-dependent	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Hence	NULL
using	NULL
a	NULL
maximally	NULL
effective	NULL
gliotoxin	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
,	NULL
apoptosis	NULL
was	NULL
readily	NULL
apparent	NULL
within	NULL
2	NULL
h	NULL
and	NULL
reached	NULL
100	NULL
%	NULL
by	NULL
6	NULL
h.	NULL
At	NULL
20	NULL
h	NULL
,	NULL
when	NULL
the	NULL
rate	NULL
of	NULL
constitutive	NULL
neutrophil	NULL
apoptosis	NULL
was	NULL
58.7	NULL
+	NULL
2.9	NULL
%	NULL
,	NULL
gliotoxin	NULL
caused	NULL
100	NULL
%	NULL
apoptosis	NULL
at	NULL
all	NULL
concentrations	NULL
greater	NULL
than	NULL
0.1	NULL
ug/ml	NULL
.	NULL

The	NULL
inactive	NULL
analogue	NULL
of	NULL
gliotoxin	NULL
,	NULL
methylthiogliotoxin	NULL
,	NULL
did	NULL
not	NULL
af-	NULL
4311	NULL
fect	NULL
the	NULL
constitutive	NULL
rate	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
at	NULL
any	NULL
of	NULL
the	NULL
time	NULL
points	NULL
studied	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Neither	NULL
gliotoxin	NULL
nor	NULL
its	NULL
inactive	NULL
analogue	NULL
,	NULL
methylthiogliotoxin	NULL
,	NULL
caused	NULL
cell	NULL
necrosis	NULL
since	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
permeable	NULL
to	NULL
the	NULL
vital	NULL
dye	NULL
trypan	NULL
blue	NULL
.	NULL

Gliotoxin	NULL
Acts	NULL
Synergistically	NULL
with	NULL
TNF-a	NULL
to	NULL
Stimulate	NULL
Neutrophil	NULL
Apoptosis-In	NULL
contrast	NULL
to	NULL
many	NULL
other	NULL
hematopoetic	NULL
cells	NULL
,	NULL
human	NULL
neutrophils	NULL
appear	NULL
highly	NULL
resistant	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
induced	NULL
by	NULL
certain	NULL
agents	NULL
,	NULL
for	NULL
example	NULL
,	NULL
incubation	NULL
with	NULL
Ca**	NULL
ionophores	NULL
(	NULL
81	NULL
,	NULL
32	NULL
)	NULL
,	NULL
cAMP	NULL
elevating	NULL
agents	NULL
(	NULL
83	NULL
)	NULL
,	NULL
corticosteroids	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
(	NULL
7	NULL
)	NULL
causes	NULL
inhibition	NULL
of	NULL
apoptosis	NULL
as	NULL
does	NULL
hypoxia	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
while	NULL
TNF-	NULL
«	NULL
and	NULL
Fas-L	NULL
can	NULL
induce	NULL
neutrophil	NULL
apoptosis	NULL
,	NULL
this	NULL
effect	NULL
is	NULL
modest	NULL
and	NULL
transient	NULL
,	NULL
and	NULL
in	NULL
the	NULL
case	NULL
of	NULL
TNF-a	NULL
abolished	NULL
if	NULL
the	NULL
cells	NULL
are	NULL
initially	NULL
primed	NULL
with	NULL
platelet-activating	NULL
factor	NULL
or	NULL
LPS	NULL
(	NULL
10	NULL
,	NULL
35	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
gliotoxin	NULL
on	NULL
TNF-	NULL
«	NULL
-induced	NULL
apoptosis	NULL
in	NULL
neutrophils	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
deliberately	NULL
at	NULL
a	NULL
very	NULL
early	NULL
time	NULL
point	NULL
(	NULL
2	NULL
h	NULL
)	NULL
when	NULL
the	NULL
independent	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
even	NULL
a	NULL
maximally	NULL
effective	NULL
concentration	NULL
of	NULL
TNF-a	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
(	NULL
10	NULL
)	NULL
and	NULL
gliotoxin	NULL
(	NULL
1	NULL
ug/ml	NULL
;	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
are	NULL
only	NULL
just	NULL
apparent	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
a	NULL
major	NULL
synergy	NULL
was	NULL
observed	NULL
between	NULL
these	NULL
agents	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
which	NULL
was	NULL
apparent	NULL
even	NULL
at	NULL
gliotoxin	NULL
concentrations	NULL
as	NULL
low	NULL
as	NULL
3	NULL
ng/ml	NULL
.	NULL

Hence	NULL
,	NULL
a	NULL
concentration	NULL
of	NULL
0.1	NULL
ug/m1	NULL
gliotoxin	NULL
in	NULL
combination	NULL
with	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
caused	NULL
almost	NULL
100	NULL
%	NULL
apoptosis	NULL
at	NULL
2	NULL
h.	NULL
With	NULL
gliotoxin	NULL
alone	NULL
,	NULL
only	NULL
6	NULL
%	NULL
apoptosis	NULL
was	NULL
noted	NULL
at	NULL
2	NULL
h	NULL
,	NULL
with	NULL
just	NULL
over	NULL
65	NULL
%	NULL
at	NULL
6	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
methylthiogliotoxin	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
constitutive	NULL
apoptosis	NULL
or	NULL
TNF-a-induced	NULL
apoptosis	NULL
at	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
necrosis	NULL
in	NULL
cells	NULL
from	NULL
each	NULL
treatment	NULL
was	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
;	NULL
all	NULL
values	NULL
were	NULL
<	NULL
1	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
genuine	NULL
nature	NULL
of	NULL
both	NULL
the	NULL
intrinsic	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
gliotoxin	NULL
and	NULL
the	NULL
dramatic	NULL
synergy	NULL
with	NULL
TNF-a	NULL
was	NULL
assessed	NULL
by	NULL
comparing	NULL
the	NULL
quantitative	NULL
morphological	NULL
effects	NULL
of	NULL
these	NULL
agents	NULL
with	NULL
their	NULL
effects	NULL
on	NULL
annexin	NULL
V	NULL
binding	NULL
and	NULL
DNA	NULL
frag-mentation	NULL
.	NULL

The	NULL
changes	NULL
from	NULL
normal	NULL
cell	NULL
morphology	NULL
to	NULL
apoptotic	NULL
morphology	NULL
are	NULL
clearly	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
;	NULL
where	NULL
non-apoptotic	NULL
neutrophils	NULL
contain	NULL
a	NULL
multilobed	NULL
nucleus	NULL
and	NULL
the	NULL
apoptotic	NULL
cells	NULL
have	NULL
a	NULL
shrunken	NULL
appearance	NULL
with	NULL
pyknotic	NULL
nu-clei	NULL
.	NULL

These	NULL
data	NULL
can	NULL
be	NULL
compared	NULL
with	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
where	NULL
the	NULL
annexin	NULL
V	NULL
``	NULL
low	NULL
peak	NULL
``	NULL
represents	NULL
non-apoptotic	NULL
cells	NULL
and	NULL
the	NULL
annexin	NULL
V	NULL
``	NULL
high	NULL
peak	NULL
``	NULL
represents	NULL
apoptotic	NULL
cells	NULL
since	NULL
the	NULL
fluorescein	NULL
isothiocyanate-labeled	NULL
annexin	NULL
V	NULL
binds	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Ca**	NULL
to	NULL
phosphatidylserine	NULL
exposed	NULL
on	NULL
the	NULL
outer	NULL
membrane	NULL
of	NULL
apoptotic	NULL
cells	NULL
.	NULL

Although	NULL
control	NULL
cells	NULL
at	NULL
2	NULL
h	NULL
exhibit	NULL
low	NULL
rates	NULL
of	NULL
apoptosis	NULL
,	NULL
the	NULL
small	NULL
increase	NULL
in	NULL
annexin	NULL
V	NULL
positive	NULL
cells	NULL
observed	NULL
with	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
alone	NULL
is	NULL
again	NULL
dramatically	NULL
augmented	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
reagents	NULL
together	NULL
.	NULL

Analysis	NULL
by	NULL
DNA	NULL
fragmentation	NULL
also	NULL
demonstrates	NULL
that	NULL
cells	NULL
cultured	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
above	NULL
reagents	NULL
exhibit	NULL
the	NULL
classical	NULL
``	NULL
ladder	NULL
``	NULL
of	NULL
DNA	NULL
fragmentation	NULL
associated	NULL
with	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Combined	NULL
Glictoxin	NULL
and	NULL
TNF-a	NULL
Treatment	NULL
Does	NULL
Not	NULL
Cause	NULL
Necrosis-Although	NULL
our	NULL
initial	NULL
studies	NULL
using	NULL
trypan	NULL
blue	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
plasma	NULL
membrane	NULL
integrity	NULL
indicated	NULL
that	NULL
gliotoxin	NULL
,	NULL
both	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
TNF-	NULL
«	NULL
,	NULL
induced	NULL
a	NULL
purely	NULL
apoptotic	NULL
form	NULL
of	NULL
cell	NULL
death	NULL
,	NULL
we	NULL
felt	NULL
it	NULL
was	NULL
important	NULL
to	NULL
validate	NULL
this	NULL
further	NULL
by	NULL
assessing	NULL
necrosis	NULL
in	NULL
an	NULL
independent	NULL
manner	NULL
using	NULL
propidium	NULL
iodide	NULL
staining	NULL
detected	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Fig	NULL
.	NULL

3D	NULL
shows	NULL
the	NULL
profile	NULL
of	NULL
neutrophils	NULL
4	NULL
h	NULL
following	NULL
treatment	NULL
with	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
and	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
where	NULL
,	NULL
despite	NULL
apoptotic	NULL
rates	NULL
of	NULL
100	NULL
%	NULL
,	NULL
almost	NULL
all	NULL
cells	NULL
showed	NULL
low	NULL
fluorescence	NULL
indicating	NULL
that	NULL
the	NULL
cell	NULL
membrane	NULL
had	NULL
remained	NULL
intact	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
cells	NULL
cultured	NULL
initially	NULL
with	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
were	NULL
then	NULL
heat-treated	NULL
(	NULL
60	NULL
°C	NULL
,	NULL
5	NULL
min	NULL
)	NULL
to	NULL
ensure	NULL
100	NULL
%	NULL
necrosis	NULL
.	NULL

This	NULL
resulted	NULL
in	NULL
a	NULL
uniform	NULL
and	NULL
major	NULL
increase	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
4312	NULL
A	NULL
100	NULL
7	NULL
80	NULL
4	NULL
.A	NULL
8	NULL
60	NULL
{	NULL
ty	NULL
a	NULL
.	NULL

0	NULL
a	NULL
.	NULL

<	NULL
<	NULL
40	NULL
{	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
gliotoxin	NULL
,	NULL
meth-	NULL
3°	NULL
ylthiogliotoxin	NULL
,	NULL
and	NULL
TNF	NULL
on	NULL
human	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
neutro-	NULL
20	NULL
<	NULL
phils	NULL
(	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
87	NULL
°C	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
gliotoxin	NULL
,	NULL
plus	NULL
or	NULL
0	NULL
minus	NULL
TNF-	NULL
@	NULL
.	NULL

After	NULL
2	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
0	NULL
0.001	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparations	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

A	NULL
,	NULL
represents	NULL
the	NULL
effect	NULL
B	NULL
of	NULL
gliotoxin	NULL
(	NULL
0.001-80	NULL
ug/ml	NULL
)	NULL
on	NULL
TNF-	NULL
@	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
-induced	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

60	NULL
B	NULL
,	NULL
represents	NULL
the	NULL
effect	NULL
of	NULL
methylthiogliotoxin	NULL
(	NULL
80	NULL
ug/ml	NULL
)	NULL
or	NULL
gliotoxin	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
,	NULL
plus	NULL
or	NULL
minus	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
40	NULL
<	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

%	NULL
Apoptosis	NULL
20	NULL
4	NULL
propidium	NULL
iodide	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

These	NULL
data	NULL
coincide	NULL
completely	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
trypan	NULL
blue	NULL
staining	NULL
and	NULL
confirm	NULL
that	NULL
these	NULL
cells	NULL
had	NULL
undergone	NULL
apoptotic	NULL
cell	NULL
death	NULL
and	NULL
were	NULL
not	NULL
necrotic	NULL
.	NULL

Gliotoxin	NULL
Inhibits	NULL
the	NULL
Survival	NULL
Effect	NULL
of	NULL
LPS-To	NULL
investigate	NULL
whether	NULL
gliotoxin	NULL
could	NULL
modulate	NULL
the	NULL
effects	NULL
of	NULL
LPS	NULL
on	NULL
the	NULL
rate	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
we	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
where	NULL
neutrophils	NULL
were	NULL
cultured	NULL
for	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
20	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
,	NULL
gliotoxin	NULL
,	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
LPS	NULL
plus	NULL
gliotoxin	NULL
and	NULL
apoptosis	NULL
assessed	NULL
morphologically	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
previously	NULL
(	NULL
7	NULL
)	NULL
LPS	NULL
caused	NULL
an	NULL
inhibition	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
at	NULL
20	NULL
h	NULL
when	NULL
compared	NULL
with	NULL
control	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
suppressive	NULL
effect	NULL
of	NULL
LPS	NULL
was	NULL
prevented	NULL
by	NULL
the	NULL
strong	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
gliotoxin	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
unlike	NULL
co-culture	NULL
of	NULL
gliotoxin	NULL
plus	NULL
TNF-a	NULL
,	NULL
no	NULL
synergistic	NULL
induction	NULL
of	NULL
apoptosis	NULL
was	NULL
observed	NULL
when	NULL
LPS	NULL
was	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
gliotoxin	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Gliotoxin	NULL
Unmasks	NULL
the	NULL
Ability	NULL
of	NULL
TNF-a	NULL
to	NULL
Induce	NULL
Eosinophil	NULL
Apoptosis-To	NULL
explore	NULL
whether	NULL
the	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
gliotoxin	NULL
was	NULL
restricted	NULL
to	NULL
neutrophils	NULL
,	NULL
a	NULL
similar	NULL
set	NULL
of	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
human	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
isolated	NULL
from	NULL
mildly	NULL
atopic	NULL
individuals	NULL
.	NULL

While	NULL
these	NULL
cells	NULL
display	NULL
a	NULL
similar	NULL
capacity	NULL
to	NULL
undergo	NULL
constitutive	NULL
apoptosis	NULL
when	NULL
aged	NULL
in	NULL
vitro	NULL
,	NULL
this	NULL
process	NULL
is	NULL
much	NULL
slower	NULL
than	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
neutrophil	NULL
and	NULL
is	NULL
differentially	NULL
regulated	NULL
being	NULL
,	NULL
for	NULL
example	NULL
,	NULL
stimulated	NULL
rather	NULL
than	NULL
inhibited	NULL
by	NULL
corticosteroids	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
gliotoxin	NULL
on	NULL
eosinophil	NULL
apo-	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
O	NULL
-	NULL
TNF	NULL
H	NULL
+	NULL
TNF	NULL
0.003	NULL
0.01	NULL
0.03	NULL
0.1	NULL
0.3	NULL
1	NULL
3	NULL
10	NULL
30	NULL
Gliotoxin	NULL
(	NULL
ug/ml	NULL
)	NULL
{	NULL
A	NULL
Control	NULL
MethylIthiogliotoxin	NULL
(	NULL
30	NULL
ug/m	NULL
!	NULL
)	NULL

MGliotoxin	NULL
(	NULL
30	NULL
ug/ml	NULL
)	NULL
a	NULL
-	NULL
TNF	NULL
+	NULL
TNF	NULL
ptosis	NULL
at	NULL
4	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
TNF-a	NULL
«	NULL
.	NULL

The	NULL
results	NULL
,	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
demonstrated	NULL
that	NULL
gliotoxin	NULL
caused	NULL
a	NULL
similar	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
eosinophils	NULL
(	NULL
EC	NULL
;	NULL
,	NULL
=	NULL
0.37	NULL
+	NULL
0.22	NULL
ug/ml	NULL
)	NULL
and	NULL
caused	NULL
a	NULL
synergistic	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
apoptosis	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
co-cultured	NULL
with	NULL
TNF-a	NULL
.	NULL

This	NULL
latter	NULL
observation	NULL
was	NULL
all	NULL
the	NULL
more	NULL
striking	NULL
since	NULL
in	NULL
eosinophils	NULL
,	NULL
TNF-a	NULL
treatment	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
rate	NULL
of	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
almost	NULL
100	NULL
%	NULL
apoptosis	NULL
was	NULL
observed	NULL
using	NULL
a	NULL
gliotoxin	NULL
concentration	NULL
of	NULL
0.1	NULL
ug/ml	NULL
plus	NULL
TNF-a	NULL
«	NULL
at	NULL
a	NULL
time	NULL
point	NULL
of	NULL
4	NULL
h.	NULL
In	NULL
comparison	NULL
,	NULL
eosinophils	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
gliotoxin	NULL
would	NULL
normally	NULL
show	NULL
only	NULL
40	NULL
%	NULL
apoptosis	NULL
at	NULL
a	NULL
40-h	NULL
time	NULL
point	NULL
(	NULL
2	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Necrosis	NULL
in	NULL
these	NULL
cells	NULL
was	NULL
<	NULL
2	NULL
%	NULL
and	NULL
the	NULL
inactive	NULL
analogue	NULL
of	NULL
gliotoxin	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
either	NULL
the	NULL
constitutive	NULL
rate	NULL
of	NULL
apoptosis	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
TNF-a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
neutrophils	NULL
,	NULL
eosinophils	NULL
demonstrated	NULL
classic	NULL
apoptotic	NULL
morphology	NULL
when	NULL
treated	NULL
with	NULL
these	NULL
agents	NULL
.	NULL

Gliotoxin	NULL
Causes	NULL
Inhibition	NULL
of	NULL
an	NULL
Inducible	NULL
Isoform	NULL
of	NULL
NF-	NULL
«	NULL
B-Recent	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
NF-	NULL
«	NULL
kB	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
rate	NULL
of	NULL
apoptosis	NULL
in	NULL
certain	NULL
transformed	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
because	NULL
gliotoxin	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
act	NULL
as	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
28	NULL
)	NULL
experiments	NULL
were	NULL
designed	NULL
to	NULL
identify	NULL
and	NULL
characterize	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
human	NULL
neutrophils	NULL
and	NULL
determine	NULL
if	NULL
gliotoxin	NULL
could	NULL
inhibit	NULL
such	NULL
activity	NULL
.	NULL

Preliminary	NULL
time	NULL
course	NULL
data	NULL
established	NULL
90	NULL
min	NULL
as	NULL
the	NULL
optimal	NULL
time	NULL
to	NULL
examine	NULL
basal	NULL
,	NULL
gliotoxin	NULL
,	NULL
and	NULL
TNF-a	NULL
regulated	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
gliotoxin	NULL
and	NULL
TNF-a	NULL
on	NULL
neutrophil	NULL
morphology	NULL
,	NULL
phosphatidylserine	NULL
expression	NULL
,	NULL
and	NULL
cell	NULL
membrane	NULL
integrity	NULL
.	NULL

A	NULL
,	NULL
cytocentrifuge	NULL
preparations	NULL
of	NULL
human	NULL
neutrophils	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
at	NULL
37°C	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
alone	NULL
(	NULL
control	NULL
)	NULL
,	NULL
plus	NULL
TNF-a	NULL
,	NULL
plus	NULL
gliotoxin	NULL
,	NULL
or	NULL
with	NULL
both	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
at	NULL
the	NULL
concentrations	NULL
shown	NULL
.	NULL

Neutrophils	NULL
treated	NULL
with	NULL
both	NULL
reagents	NULL
all	NULL
clearly	NULL
show	NULL
apoptotic	NULL
morphology	NULL
.	NULL

B	NULL
,	NULL
after	NULL
2	NULL
h	NULL
in	NULL
culture	NULL
at	NULL
87°C	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
Iscove	NULL
's	NULL
DMEM	NULL
,	NULL
TNF-a	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/m1	NULL
)	NULL
,	NULL
or	NULL
with	NULL
both	NULL
TNF-a	NULL
plus	NULL
gliotoxin	NULL
were	NULL
resuspended	NULL
and	NULL
incubated	NULL
with	NULL
fluorescein	NULL
isothiocyanate-labeled	NULL
recombinant	NULL
human	NULL
annexin	NULL
V	NULL
to	NULL
determine	NULL
phosphatidylserine	NULL
expression	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
fixed	NULL
and	NULL
analyzed	NULL
using	NULL
an	NULL
EPICS	NULL
Profile	NULL
II	NULL
.	NULL

Mean	NULL
fluorescence	NULL
values	NULL
are	NULL
shown	NULL
for	NULL
a	NULL
minimum	NULL
of	NULL
5,000	NULL
cells	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

C	NULL
,	NULL
DNA	NULL
fragmentation	NULL
in	NULL
human	NULL
neutrophils	NULL
treated	NULL
with	NULL
TNF-a	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
,	NULL
or	NULL
both	NULL
reagents	NULL
together	NULL
for	NULL
2	NULL
h.	NULL
DNA	NULL
was	NULL
prepared	NULL
as	NULL
detailed	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
``	NULL
;	NULL
lane	NULL
I	NULL
,	NULL
DNA	NULL
marker	NULL
(	NULL
1-kilobase	NULL
ladder	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
freshly	NULL
isolated	NULL
neutrophils	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
TNF-a	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
gliotoxin	NULL
,	NULL
2	NULL
h	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
co-culture	NULL
with	NULL
gliotoxin	NULL
and	NULL
TNF-a	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
DNA	NULL
marker	NULL
(	NULL
1-kilobase	NULL
ladder	NULL
)	NULL
.	NULL

D	NULL
,	NULL
to	NULL
assess	NULL
cell	NULL
membrane	NULL
integrity	NULL
,	NULL
cells	NULL
treated	NULL
with	NULL
both	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
,	NULL
which	NULL
induced	NULL
100	NULL
%	NULL
apoptosis	NULL
even	NULL
by	NULL
2	NULL
h	NULL
,	NULL
were	NULL
resuspended	NULL
and	NULL
incubated	NULL
with	NULL
propidium	NULL
iodide	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
analyzed	NULL
using	NULL
an	NULL
EPICS	NULL
Profile	NULL
II	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
cells	NULL
from	NULL
this	NULL
preparation	NULL
was	NULL
heated	NULL
as	NULL
indicated	NULL
under	NULL
``	NULL
Experimental	NULL
Proce-dures	NULL
``	NULL
to	NULL
produce	NULL
100	NULL
%	NULL
necrosis	NULL
(	NULL
doffed	NULL
line	NULL
)	NULL
.	NULL

Mean	NULL
fluorescence	NULL
values	NULL
are	NULL
shown	NULL
for	NULL
a	NULL
minimum	NULL
of	NULL
5,000	NULL
cells	NULL
for	NULL
each	NULL
condition	NULL
.	NULL

NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
4313	NULL
Control	NULL
2	NULL
h	NULL
Apoptosis	NULL
(	NULL
1.3	NULL
%	NULL
)	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
2	NULL
h	NULL
Apoptosis	NULL
(	NULL
7.3	NULL
%	NULL
)	NULL
BA	NULL
a	NULL
*C	NULL
``	NULL
w	NULL
4	NULL
a	NULL
``	NULL
«	NULL
f*	NULL
4	NULL
I	NULL
.	NULL

’	NULL
’	NULL
*	NULL
we	NULL
.	NULL

ﬂ	NULL
&	NULL
``	NULL
}	NULL
-	NULL
’	NULL
..~	NULL
,	NULL
~	NULL
.u	NULL
a*	NULL
Gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
2	NULL
h	NULL
Apoptosis	NULL
(	NULL
1.3	NULL
%	NULL
)	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
+	NULL
Gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
Apoptosis	NULL
(	NULL
100	NULL
%	NULL
)	NULL
~*	NULL
*+	NULL
E	NULL
C	NULL
3	NULL
\~	NULL
@	NULL
€	NULL
6	NULL
oss	NULL
vo	NULL
*	NULL
|	NULL
no	NULL
w	NULL
ltt	NULL
u	NULL
.	NULL

42	NULL
:	NULL
|	NULL
,	NULL
Tula	NULL
°	NULL
{	NULL
|	NULL
)	NULL
.¢	NULL
.	NULL

*	NULL
%	NULL
!	NULL

*	NULL
SC	NULL
Cag	NULL
>	NULL
Count	NULL
Count	NULL
Control	NULL
TNF-o	NULL
10	NULL
100	NULL
1000	NULL
I	NULL
10	NULL
100	NULL
1000	NULL
Gliotoxin	NULL
TNF-a	NULL
plus	NULL
gliotoxin	NULL
10	NULL
100	NULL
1000	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
LFL1	NULL
LFL	NULL
]	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
this	NULL
time	NULL
point	NULL
also	NULL
coincided	NULL
with	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
biologically	NULL
observable	NULL
effect	NULL
of	NULL
gliotoxin	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A-C	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
EMSAs	NULL
performed	NULL
on	NULL
neutrophil	NULL
nuclear	NULL
extracts	NULL
indicated	NULL
the	NULL
presence	NULL
of	NULL
3	NULL
discrete	NULL
bands	NULL
in	NULL
these	NULL
gels	NULL
.	NULL

To	NULL
ascertain	NULL
which	NULL
of	NULL
these	NULL
bands	NULL
were	NULL
specifically	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
was	NULL
included	NULL
in	NULL
the	NULL
label	NULL
ing	NULL
reaction	NULL
to	NULL
displace	NULL
specific	NULL
binding	NULL
;	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
bands	NULL
were	NULL
identified	NULL
and	NULL
designated	NULL
A	NULL
and	NULL
B	NULL
.	NULL

In	NULL
both	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
0-90	NULL
min	NULL
)	NULL
and	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
,	NULL
0-120	NULL
min	NULL
)	NULL
treated	NULL
cells	NULL
,	NULL
no	NULL
change	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
band	NULL
B	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
,	NULL
together	NULL
with	NULL
its	NULL
strong	NULL
expression	NULL
in	NULL
freshly	NULL
prepared	NULL
untreated	NULL
neu-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
4314	NULL
3	NULL
5	NULL
O	NULL
1	NULL
10	NULL
100	NULL
1000	NULL
LFL1	NULL
F1G.3-continued	NULL
100	NULL
-	NULL
-e-	NULL
Control	NULL
-®-	NULL
Glictoxin	NULL
-M-	NULL
LPS	NULL
80	NULL
--	NULL
&	NULL
-	NULL
Gliotoxin	NULL
+	NULL
LPS	NULL
E4	NULL
A	NULL
8	NULL
g.	NULL
0	NULL
c.	NULL
a	NULL
a€	NULL
1	NULL
24	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
gliotoxin	NULL
alone	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
on	NULL
human	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
neutrophils	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
at	NULL
37°C	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
alone	NULL
and	NULL
treated	NULL
with	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
,	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
.	NULL

At	NULL
the	NULL
time	NULL
periods	NULL
indicated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparation	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
*	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
3-5	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

trophils	NULL
suggests	NULL
that	NULL
this	NULL
band	NULL
represents	NULL
a	NULL
form	NULL
of	NULL
constitu-tively	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

However	NULL
,	NULL
band	NULL
A	NULL
was	NULL
markedly	NULL
up-regu-lated	NULL
by	NULL
TNF-a	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
,	NULL
and	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
gliotoxin	NULL
caused	NULL
both	NULL
a	NULL
concentration-dependent	NULL
inhibition	NULL
of	NULL
this	NULL
NF-kB	NULL
activity	NULL
and	NULL
abolished	NULL
the	NULL
TNF-a	NULL
@	NULL
stimulated	NULL
increase	NULL
in	NULL
this	NULL
band	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
densiometric	NULL
analysis	NULL
of	NULL
these	NULL
data	NULL
confirmed	NULL
that	NULL
co-treatment	NULL
of	NULL
neutrophils	NULL
with	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
at	NULL
a	NULL
maximal	NULL
effective	NULL
functional	NULL
concentration	NULL
of	NULL
0.1	NULL
ug/ml	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
inhibited	NULL
this	NULL
band	NULL
more	NULL
than	NULL
treatment	NULL
with	NULL
gliotoxin	NULL
alone	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
D	NULL
,	NULL
confirm	NULL
that	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
control	NULL
samples	NULL
at	NULL
90	NULL
min	NULL
was	NULL
inhibited	NULL
by	NULL
gliotoxin	NULL
treatment	NULL
;	NULL
a	NULL
finding	NULL
that	NULL
was	NULL
observed	NULL
at	NULL
all	NULL
other	NULL
time	NULL
points	NULL
tested	NULL
.	NULL

Further	NULL
evidence	NULL
that	NULL
strongly	NULL
supports	NULL
the	NULL
suggestion	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
is	NULL
linked	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
cell	NULL
permeable	NULL
NF-	NULL
«	NULL
B	NULL
inhibitory	NULL
peptide	NULL
,	NULL
SN50	NULL
(	NULL
37	NULL
)	NULL
,	NULL
also	NULL
increased	NULL
the	NULL
rate	NULL
of	NULL
constitutive	NULL
neutrophil	NULL
apoptosis	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
less	NULL
than	NULL
5	NULL
%	NULL
of	NULL
the	NULL
peptide	NULL
reportedly	NULL
enters	NULL
the	NULL
cell	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Hence	NULL
at	NULL
6	NULL
h	NULL
,	NULL
the	NULL
SN50	NULL
peptide	NULL
increased	NULL
neutrophil	NULL
apoptosis	NULL
from	NULL
4.7	NULL
+	NULL
1.2	NULL
to	NULL
15.0	NULL
+	NULL
3.2	NULL
%	NULL
(	NULL
n	NULL
=	NULL
8	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
less	NULL
active	NULL
peptide	NULL
SN5OM	NULL
only	NULL
increased	NULL
apoptosis	NULL
from	NULL
4.7	NULL
+	NULL
1.2	NULL
to	NULL
5.6	NULL
+	NULL
0.8	NULL
%	NULL
(	NULL
n	NULL
=	NULL
8	NULL
)	NULL
.	NULL

Similar	NULL
effects	NULL
on	NULL
neutrophil	NULL
apoptosis	NULL
were	NULL
seen	NULL
at	NULL
20	NULL
h	NULL
and	NULL
eosinophil	NULL
apoptosis	NULL
at	NULL
20	NULL
and	NULL
40	NULL
h	NULL
(	NULL
Table	NULL
I	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Other	NULL
agents	NULL
known	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
similarly	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
A	NULL
100	NULL
80	NULL
%	NULL
Apoptosis	NULL
40	NULL
0	NULL
0.001	NULL
0.003	NULL
0.01	NULL
0.03	NULL
0.1	NULL
0.3	NULL
1	NULL
3	NULL
Gliotoxin	NULL
(	NULL
ug/ml	NULL
)	NULL
100	NULL
a-	NULL
TNF	NULL
m+TNF	NULL
80	NULL
60	NULL
40	NULL
%	NULL
Apoptosis	NULL
0	NULL
mass	NULL
___	NULL
0	NULL
0.01	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
gliotoxin	NULL
alone	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TNF-a	NULL
on	NULL
human	NULL
eosinophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
eosinophils	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
at	NULL
37	NULL
°C	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
alone	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
gliotoxin	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
@	NULL
.	NULL

At	NULL
the	NULL
time	NULL
periods	NULL
indicated	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparation	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

A	NULL
,	NULL
represents	NULL
the	NULL
effects	NULL
of	NULL
gliotoxin	NULL
(	NULL
0-3	NULL
ug/ml	NULL
)	NULL
on	NULL
eosinophil	NULL
apoptosis	NULL
after	NULL
4	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

B	NULL
,	NULL
represents	NULL
the	NULL
effects	NULL
gliotoxin	NULL
(	NULL
0-0.3	NULL
ug/ml	NULL
)	NULL
with	NULL
or	NULL
without	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

on	NULL
eosinophil	NULL
apoptosis	NULL
after	NULL
a	NULL
4-h	NULL
culture	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
3	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

0.03	NULL
0.1	NULL
0.3	NULL
Gliotoxin	NULL
(	NULL
ug/ml	NULL
)	NULL
induced	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

The	NULL
proteasome	NULL
inhibitor	NULL
,	NULL
MG-132	NULL
(	NULL
38	NULL
)	NULL
and	NULL
the	NULL
NF-kB	NULL
inhibitor	NULL
curcumin	NULL
(	NULL
39	NULL
)	NULL
caused	NULL
a	NULL
time-dependent	NULL
induction	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

PDTC	NULL
,	NULL
that	NULL
acts	NULL
as	NULL
both	NULL
a	NULL
radical	NULL
scavenger	NULL
and	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
40	NULL
)	NULL
,	NULL
also	NULL
caused	NULL
a	NULL
significant	NULL
induction	NULL
of	NULL
apoptosis	NULL
when	NULL
cultured	NULL
with	NULL
neutrophils	NULL
for	NULL
20	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
treating	NULL
neutrophils	NULL
with	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
,	NULL
20	NULL
min	NULL
)	NULL
which	NULL
we	NULL
have	NULL
previously	NULL
reported	NULL
to	NULL
induce	NULL
a	NULL
profound	NULL
inhibition	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
(	NULL
7	NULL
)	NULL
was	NULL
found	NULL
to	NULL
cause	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
inducible	NULL
isoform	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
;	NULL
and	NULL
this	NULL
induction	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
Apoptosis	NULL
by	NULL
Gliotoxin	NULL
Is	NULL
Dependent	NULL
on	NULL
Activation	NULL
of	NULL
the	NULL
Caspase-cascade	NULL
Pathway-We	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
the	NULL
early	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
human	NULL
neutrophils	NULL
requires	NULL
activation	NULL
of	NULL
both	NULL
TNF-55	NULL
and	NULL
TNF-75	NULL
receptor	NULL
subtypes	NULL
and	NULL
thereby	NULL
differs	NULL
significantly	NULL
from	NULL
the	NULL
priming	NULL
effect	NULL
of	NULL
TNF-a	NULL
which	NULL
is	NULL
signaled	NULL
via	NULL
the	NULL
TNF-p55	NULL
receptor	NULL
alone	NULL
(	NULL
10	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
gliotoxin	NULL
and	NULL
the	NULL
marked	NULL
synergism	NULL
displayed	NULL
by	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
were	NULL
mediated	NULL
via	NULL
activation	NULL
of	NULL
the	NULL
caspase	NULL
pathway	NULL
,	NULL
we	NULL
co-incubated	NULL
neutrophils	NULL
with	NULL
TNF-a	NULL
,	NULL
gliotoxin	NULL
,	NULL
and	NULL
zVAD-fmk	NULL
.	NULL

At	NULL
2	NULL
h	NULL
,	NULL
zVAD-fmk	NULL
completely	NULL
inhibited	NULL
the	NULL
increase	NULL
in	NULL
apoptosis	NULL
induced	NULL
by	NULL
gliotoxin	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
by	NULL
both	NULL
factors	NULL
together	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
factors	NULL
alone	NULL
,	NULL
or	NULL
together	NULL
,	NULL
is	NULL
dependent	NULL
on	NULL
caspase	NULL
activation	NULL
.	NULL

Gliotoxin	NULL
May	NULL
Enhance	NULL
TNF-a	NULL
«	NULL
-induced	NULL
Apoptosis	NULL
by	NULL
Inhibiting	NULL
Production	NULL
of	NULL
a	NULL
Survival	NULL
Factor-Taken	NULL
together	NULL
,	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
.	NULL

«	NULL
-A	NULL
500	NULL
~	NULL
400	NULL
300	NULL
4	NULL
200	NULL
7	NULL
Relative	NULL
OD	NULL
value	NULL
100	NULL
7	NULL
0	NULL
~	NULL
TNF-a	NULL
.	NULL

Gliotoxin	NULL
(	NULL
b	NULL
)	NULL
Control	NULL
TNF-a	NULL
Gliotoxin	NULL
(	NULL
a	NULL
)	NULL
_	NULL
Gliotoxin	NULL
(	NULL
b	NULL
)	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
gliotoxin	NULL
and	NULL
TNF-	NULL
«	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
mobilization	NULL
.	NULL

A	NULL
,	NULL
EMSA	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
neutrophils	NULL
treated	NULL
with	NULL
control	NULL
buffer	NULL
:	NULL
lane	NULL
1	NULL
,	NULL
TNF-a	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
gliotoxin	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
pg/ml	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
and	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

B	NULL
,	NULL
EMSA	NULL
showing	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
inducible	NULL
isoform	NULL
(	NULL
band	NULL
A	NULL
)	NULL
by	NULL
LPS	NULL
(	NULL
a	NULL
known	NULL
inhibitor	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
)	NULL
after	NULL
20	NULL
min	NULL
culture	NULL
:	NULL
Zane	NULL
1	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
LPS	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
;	NULL
and	NULL
lane	NULL
3	NULL
,	NULL
LPS	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
.	NULL

C	NULL
,	NULL
EMSA	NULL
showing	NULL
displacement	NULL
of	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
bands	NULL
by	NULL
excess	NULL
cold	NULL
oligonucleotide	NULL
probe	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
control	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
TNF-	NULL
«	NULL
@	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
TNF-	NULL
@	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
50-fold	NULL
excess	NULL
cold	NULL
oligonucleotide	NULL
;	NULL
Zane	NULL
4	NULL
,	NULL
TNF	NULL
-	NULL
@	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
100-fold	NULL
excess	NULL
cold	NULL
oligonucleotide	NULL
.	NULL

Only	NULL
the	NULL
bands	NULL
marked	NULL
A	NULL
and	NULL
B	NULL
are	NULL
specific	NULL
.	NULL

D	NULL
,	NULL
densiometry	NULL
scanning	NULL
of	NULL
band	NULL
A	NULL
from	NULL
the	NULL
EMSA	NULL
shown	NULL
in	NULL
A	NULL
.	NULL

This	NULL
shows	NULL
the	NULL
reduction	NULL
of	NULL
an	NULL
inducible	NULL
isoform	NULL
of	NULL
NF-xB	NULL
by	NULL
gliotoxin	NULL
(	NULL
a	NULL
=	NULL
1	NULL
ug/ml	NULL
;	NULL
b	NULL
=	NULL
0.1	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
further	NULL
inhibition	NULL
by	NULL
co-treatment	NULL
with	NULL
TNF-a	NULL
plus	NULL
gliotoxin	NULL
(	NULL
b	NULL
)	NULL
.	NULL

above	NULL
results	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
NF-kB	NULL
may	NULL
inhibit	NULL
or	NULL
restrain	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
which	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
parallel	NULL
activation	NULL
of	NULL
the	NULL
4315	NULL
TaBLE	NULL
I	NULL
The	NULL
effect	NULL
of	NULL
NF-xB	NULL
inhibitory	NULL
peptides	NULL
on	NULL
human	NULL
neutrophil	NULL
apoptosis	NULL
Human	NULL
neutrophils	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
without	NULL
autologous	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
control	NULL
buffer	NULL
,	NULL
SN50	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
SN5OM	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
15	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
,	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
(	NULL
final	NULL
concentration	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
after	NULL
6	NULL
and	NULL
20	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparations	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

All	NULL
values	NULL
are	NULL
from	NULL
n	NULL
=	NULL
three	NULL
separate	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Treatment	NULL
Time	NULL
Mean	NULL
S.E	NULL
.	NULL

%	NULL
apoptosis	NULL
Control	NULL
(	NULL
buffer	NULL
)	NULL
6h	NULL
4.7	NULL
1.2	NULL
SN50	NULL
(	NULL
active	NULL
)	NULL
6h	NULL
15.0°	NULL
3.3	NULL
SN5OM	NULL
(	NULL
less-active	NULL
)	NULL
6h	NULL
6.8	NULL
5.6	NULL
Control	NULL
(	NULL
buffer	NULL
)	NULL
20h	NULL
58.9	NULL
7.7	NULL
SN50	NULL
(	NULL
active	NULL
)	NULL
20h	NULL
81.4°	NULL
2.7	NULL
SN5OM	NULL
(	NULL
less-active	NULL
)	NULL
20h	NULL
70.3	NULL
8.2	NULL
*	NULL
Represents	NULL
significance	NULL
differences	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
from	NULL
the	NULL
appropriate	NULL
control	NULL
.	NULL

A	NULL
100	NULL
-	NULL
@	NULL
-	NULL
Control	NULL
-	NULL
&	NULL
-	NULL
Curcumin	NULL
in	NULL
80	NULL
-	NULL
#	NULL
-	NULL
MG-132	NULL
P34	NULL
2	NULL
60	NULL
c.	NULL
2.	NULL
g	NULL
40	NULL
s	NULL
20	NULL
o	NULL
¥	NULL
u	NULL
0	NULL
24	NULL
100	NULL
7	NULL
75	NULL
%	NULL
apoptosis	NULL
50	NULL
Control	NULL
MG-132	NULL
Curcumin	NULL
PDTC	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
other	NULL
NF-kB	NULL
inhibitors	NULL
on	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
neutrophils	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
Iscove	NULL
's	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
reagent	NULL
.	NULL

A	NULL
,	NULL
neutrophils	NULL
were	NULL
treated	NULL
with	NULL
MG	NULL
182	NULL
(	NULL
20	NULL
uM	NULL
)	NULL
and	NULL
curcumin	NULL
(	NULL
20	NULL
pM	NULL
)	NULL
at	NULL
the	NULL
time	NULL
periods	NULL
indicated	NULL
;	NULL
B	NULL
,	NULL
neutrophils	NULL
were	NULL
treated	NULL
with	NULL
MG-132	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
,	NULL
curcumin	NULL
(	NULL
20	NULL
uM	NULL
)	NULL
,	NULL
and	NULL
PDTC	NULL
(	NULL
300	NULL
um	NULL
)	NULL
for	NULL
20	NULL
h.	NULL
After	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparations	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
+	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
three	NULL
to	NULL
six	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

caspase	NULL
pathway	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
this	NULL
most	NULL
likely	NULL
reflects	NULL
the	NULL
production	NULL
of	NULL
a	NULL
protein	NULL
or	NULL
proteins	NULL
which	NULL
act	NULL
to	NULL
suppress	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
caspase	NULL
pathway	NULL
and	NULL
thus	NULL
protect	NULL
granulocytes	NULL
from	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
this	NULL
cytokine	NULL
was	NULL
investigated	NULL
by	NULL
incubating	NULL
neutrophils	NULL
with	NULL
TNF-a	NULL
and	NULL
cyclohexi-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
4816	NULL
A	NULL
100	NULL
so	NULL
P3	NULL
t	NULL
g	NULL
so	NULL
g.	NULL
0	NULL
o	NULL
.	NULL

<	NULL
40	NULL
&	NULL
&	NULL
20	NULL
W	NULL
o	NULL
CG	NULL
Ra	NULL
a	NULL
&	NULL
&	NULL
«	NULL
°	NULL
&	NULL
__	NULL
T	NULL
*	NULL
7916	NULL
“	NULL
v9	NULL
?	NULL

88	NULL
s	NULL
``	NULL
G	NULL
sy	NULL
R	NULL
o	NULL
659°	NULL
é	NULL
u	NULL
’	NULL
é	NULL
xév	NULL
.	NULL

xév	NULL
.	NULL

0	NULL
x	NULL
&	NULL
&	NULL
k°+	NULL
&	NULL
x40	NULL
;	NULL
3°	NULL
gC	NULL
c	NULL
&	NULL
``	NULL
100	NULL
80	NULL
.	NULL

w	NULL
60	NULL
0	NULL
B	NULL
a	NULL
a	NULL
40	NULL
<	NULL
I	NULL
s	NULL
20	NULL
0	NULL
x	NULL
.	NULL

éxbe	NULL
&	NULL
&	NULL
$	NULL
<	NULL
5§b	NULL
1	NULL
&	NULL
5	NULL
“	NULL
36s	NULL
.	NULL

16g	NULL
.	NULL

&	NULL
&	NULL
3	NULL
``	NULL
AV	NULL
?	NULL

AV	NULL
?	NULL

AV	NULL
?	NULL

AV	NULL
?	NULL

sC	NULL
o	NULL
``	NULL
4	NULL
,	NULL
*	NULL
«	NULL
4	NULL
,	NULL
4	NULL
&	NULL
F	NULL
&	NULL
#	NULL
4	NULL
}	NULL
x	NULL
&	NULL
cs	NULL
8	NULL
g	NULL
&	NULL
S	NULL
&	NULL
&	NULL
66°	NULL
&	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
the	NULL
caspase	NULL
inhibitor	NULL
,	NULL
zVAD-fmk	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
,	NULL
cycloheximide	NULL
,	NULL
on	NULL
gliotoxin	NULL
,	NULL
TNF-a	NULL
,	NULL
or	NULL
gliotoxin	NULL
plus	NULL
TNF-a-induced	NULL
human	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

Human	NULL
neutrophils	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
containing	NULL
10	NULL
%	NULL
autologous	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
reagents	NULL
.	NULL

After	NULL
2	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
and	NULL
cytocentrifuge	NULL
preparation	NULL
made	NULL
.	NULL

These	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
morphologically	NULL
.	NULL

A	NULL
,	NULL
represents	NULL
the	NULL
effects	NULL
of	NULL
zVAD-fmk	NULL
(	NULL
100	NULL
pM	NULL
)	NULL
on	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/m1l	NULL
)	NULL
-	NULL
,	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m1	NULL
)	NULL
-	NULL
,	NULL
or	NULL
gliotoxin	NULL
plus	NULL
TNF-a-induced	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

B	NULL
,	NULL
represents	NULL
the	NULL
effects	NULL
of	NULL
cycloheximide	NULL
(	NULL
5	NULL
pM	NULL
)	NULL
on	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
pg/m1	NULL
)	NULL
-	NULL
,	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
gliotoxin	NULL
plus	NULL
TNF-a	NULL
«	NULL
-induced	NULL
neutrophil	NULL
apoptosis	NULL
.	NULL

All	NULL
values	NULL
represent	NULL
mean	NULL
*	NULL
S.E	NULL
.	NULL

of	NULL
n	NULL
=	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Where	NULL
not	NULL
shown	NULL
,	NULL
S.E	NULL
.	NULL

values	NULL
are	NULL
less	NULL
than	NULL
2	NULL
%	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

mide	NULL
,	NULL
a	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
cycloheximide	NULL
used	NULL
specifically	NULL
at	NULL
a	NULL
concentration	NULL
(	NULL
5	NULL
uM	NULL
)	NULL
that	NULL
alone	NULL
had	NULL
almost	NULL
no	NULL
effect	NULL
on	NULL
neutrophil	NULL
apoptosis	NULL
at	NULL
2	NULL
h	NULL
,	NULL
caused	NULL
a	NULL
synergistic	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
apoptosis	NULL
when	NULL
neutrophils	NULL
were	NULL
co-cultured	NULL
with	NULL
TNF-	NULL
@	NULL
.	NULL

This	NULL
supports	NULL
the	NULL
view	NULL
that	NULL
TNF-a	NULL
treatment	NULL
indeed	NULL
results	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
survival	NULL
protein	NULL
that	NULL
protects	NULL
these	NULL
cells	NULL
from	NULL
the	NULL
TNF	NULL
re-ceptor-caspase-dependent	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
TNF-a	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
demonstrated	NULL
that	NULL
gliotoxin	NULL
,	NULL
but	NULL
not	NULL
its	NULL
inactive	NULL
derivative	NULL
methylthiogliotoxin	NULL
,	NULL
(	NULL
a	NULL
)	NULL
induces	NULL
a	NULL
direct	NULL
time-	NULL
and	NULL
concentration-dependent	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
constitutive	NULL
apoptosis	NULL
in	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
,	NULL
(	NULL
b	NULL
)	NULL
enhances	NULL
the	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
TNF-a	NULL
«	NULL
in	NULL
neutrophils	NULL
,	NULL
and	NULL
(	NULL
c	NULL
)	NULL
reveals	NULL
the	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
eosinophils	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
extreme	NULL
care	NULL
was	NULL
taken	NULL
to	NULL
ensure	NULL
that	NULL
gliotoxin	NULL
,	NULL
at	NULL
all	NULL
time	NULL
points	NULL
and	NULL
concentrations	NULL
studied	NULL
,	NULL
was	NULL
non-toxic	NULL
and	NULL
caused	NULL
genuine	NULL
apoptosis	NULL
that	NULL
was	NULL
indistinguishable	NULL
from	NULL
later	NULL
constitutive	NULL
apoptosis	NULL
.	NULL

The	NULL
similar	NULL
effects	NULL
of	NULL
gliotoxin	NULL
in	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
and	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
required	NULL
for	NULL
maximal	NULL
enhancement	NULL
of	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
TNF-a	NULL
,	NULL
suggests	NULL
that	NULL
an	NULL
identical	NULL
underlying	NULL
mechanism	NULL
is	NULL
regulating	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
both	NULL
these	NULL
cell	NULL
types	NULL
.	NULL

However	NULL
,	NULL
although	NULL
inhibition	NULL
of	NULL
basal	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
neutrophil	NULL
apoptosis	NULL
when	NULL
induced	NULL
by	NULL
gliotoxin	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
since	NULL
gliotoxin	NULL
appears	NULL
to	NULL
block	NULL
basal	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
D	NULL
)	NULL
,	NULL
only	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
isoform	NULL
is	NULL
down-regulated	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
cell	NULL
death	NULL
driven	NULL
by	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
control	NULL
neutrophils	NULL
incubated	NULL
for	NULL
20	NULL
h	NULL
,	NULL
where	NULL
the	NULL
constitutive	NULL
rate	NULL
of	NULL
apoptosis	NULL
is	NULL
approximately	NULL
70	NULL
%	NULL
,	NULL
the	NULL
density	NULL
of	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
was	NULL
unaffected	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
the	NULL
inducible	NULL
and	NULL
constitutive	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
most	NULL
likely	NULL
reflects	NULL
differential	NULL
regulation	NULL
of	NULL
activation	NULL
,	NULL
for	NULL
example	NULL
,	NULL
by	NULL
the	NULL
involvement	NULL
of	NULL
different	NULL
isoforms	NULL
of	NULL
the	NULL
inhibitory	NULL
IxB	NULL
subunit	NULL
,	NULL
or	NULL
that	NULL
the	NULL
constitu-tively	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
formed	NULL
from	NULL
a	NULL
different	NULL
set	NULL
of	NULL
dimers	NULL
from	NULL
the	NULL
classical	NULL
RelA/p50	NULL
heterodimer	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
neutrophils	NULL
contain	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p105	NULL
(	NULL
the	NULL
p50	NULL
precursor	NULL
protein	NULL
)	NULL
as	NULL
well	NULL
as	NULL
Rel-A	NULL
(	NULL
22	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
band	NULL
we	NULL
observed	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
up-regulated	NULL
in	NULL
neutrophils	NULL
by	NULL
phagocytosis	NULL
of	NULL
IgG	NULL
opsonized	NULL
yeast	NULL
particles	NULL
(	NULL
42	NULL
)	NULL
,	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
consist	NULL
mainly	NULL
of	NULL
Rel-A/	NULL
p50	NULL
heterodimers	NULL
and	NULL
possibly	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
c-Rel	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
that	NULL
study	NULL
,	NULL
phagocytosis	NULL
of	NULL
these	NULL
particles	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
constitutive	NULL
complex	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
becomes	NULL
activated	NULL
,	NULL
via	NULL
a	NULL
mechanisms	NULL
not	NULL
involving	NULL
oxidant	NULL
generation	NULL
,	NULL
when	NULL
neutrophils	NULL
phagocytose	NULL
bacteria	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Because	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
also	NULL
activated	NULL
by	NULL
certain	NULL
pro-apoptotic	NULL
stimuli	NULL
such	NULL
as	NULL
TNF-a	NULL
«	NULL
,	NULL
this	NULL
transcription	NULL
factor	NULL
has	NULL
been	NULL
considered	NULL
as	NULL
a	NULL
possible	NULL
regulator	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Hence	NULL
,	NULL
in	NULL
some	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
appears	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
onset	NULL
of	NULL
apoptosis	NULL
(	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NF-kB	NULL
activation	NULL
has	NULL
clearly	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
anti-apoptotic	NULL
in	NULL
HT	NULL
1080	NULL
fibrosarcoma	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
and	NULL
TNF-a	NULL
induced	NULL
NF-KB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
in	NULL
Hela	NULL
and	NULL
MCF7	NULL
cells	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
in	NULL
a	NULL
non-transformed	NULL
cell	NULL
namely	NULL
the	NULL
neutrophil	NULL
,	NULL
inhibition	NULL
of	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
is	NULL
related	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Several	NULL
mechanisms	NULL
,	NULL
aside	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
,	NULL
have	NULL
been	NULL
proposed	NULL
for	NULL
the	NULL
pro-apoptotic	NULL
actions	NULL
of	NULL
gliotoxin	NULL
in	NULL
other	NULL
cells	NULL
.	NULL

Sutton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
45	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
although	NULL
this	NULL
fungal	NULL
metabolite	NULL
did	NULL
not	NULL
affect	NULL
intracellular	NULL
calcium	NULL
levels	NULL
,	NULL
there	NULL
was	NULL
a	NULL
correlation	NULL
between	NULL
increases	NULL
in	NULL
cAMP	NULL
levels	NULL
and	NULL
apoptosis	NULL
in	NULL
gliotoxin-treated	NULL
splenocytes	NULL
.	NULL

However	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
agents	NULL
that	NULL
elevate	NULL
intracellular	NULL
cAMP	NULL
inhibit	NULL
apoptosis	NULL
in	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
(	NULL
33	NULL
,	NULL
46	NULL
)	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
protein	NULL
kinase	NULL
A-dependent	NULL
phosphorylation	NULL
of	NULL
histone	NULL
H3	NULL
correlates	NULL
with	NULL
gliotoxin-in-duced	NULL
apoptosis	NULL
in	NULL
thymocytes	NULL
(	NULL
47	NULL
)	NULL
,	NULL
but	NULL
again	NULL
in	NULL
neutrophils	NULL
,	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
inhibits	NULL
apoptosis	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Although	NULL
gliotoxin	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
inhibit	NULL
protein	NULL
synthesis	NULL
(	NULL
48	NULL
)	NULL
it	NULL
is	NULL
highly	NULL
unlikely	NULL
that	NULL
this	NULL
mechanism	NULL
is	NULL
directly	NULL
responsible	NULL
for	NULL
its	NULL
pro-apoptotic	NULL
effects	NULL
:	NULL
first	NULL
,	NULL
gliotoxin	NULL
induces	NULL
apoptosis	NULL
in	NULL
thymocytes	NULL
whereas	NULL
inhibition	NULL
of	NULL
protein	NULL
synthesis	NULL
by	NULL
cycloheximide	NULL
inhibits	NULL
thymocyte	NULL
apoptosis	NULL
.	NULL

Second	NULL
,	NULL
since	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
multiple	NULL
genes	NULL
,	NULL
many	NULL
of	NULL
which	NULL
encode	NULL
for	NULL
inflammatory	NULL
mediator	NULL
synthesis	NULL
,	NULL
inactivation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
would	NULL
therefore	NULL
be	NULL
expected	NULL
to	NULL
inhibit	NULL
protein	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
synthesis	NULL
.	NULL

Third	NULL
,	NULL
while	NULL
protein	NULL
synthesis	NULL
inhibitors	NULL
do	NULL
up-reg-ulate	NULL
the	NULL
rate	NULL
of	NULL
constitutive	NULL
cell	NULL
death	NULL
in	NULL
granulocytes	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
this	NULL
response	NULL
are	NULL
very	NULL
different	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
gliotoxin	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Whyte	NULL
et	NULL
al	NULL
.	NULL

(	NULL
49	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
cycloheximide	NULL
(	NULL
50	NULL
um	NULL
)	NULL
and	NULL
actinomycin	NULL
D	NULL
(	NULL
1	NULL
uM	NULL
)	NULL
induce	NULL
apoptosis	NULL
in	NULL
approximately	NULL
30	NULL
%	NULL
of	NULL
neutrophils	NULL
by	NULL
6	NULL
h.	NULL
In	NULL
our	NULL
experiments	NULL
,	NULL
gliotoxin	NULL
(	NULL
0.1	NULL
ug/ml	NULL
)	NULL
,	NULL
induces	NULL
a	NULL
rate	NULL
of	NULL
almost	NULL
twice	NULL
this	NULL
,	NULL
whereas	NULL
1.0	NULL
ug/ml	NULL
gliotoxin	NULL
induced	NULL
100	NULL
%	NULL
neutrophil	NULL
apoptosis	NULL
by	NULL
this	NULL
time	NULL
point	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
our	NULL
own	NULL
results	NULL
with	NULL
cycloheximide	NULL
indicate	NULL
that	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
alone	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
rate	NULL
of	NULL
neutrophil	NULL
apoptosis	NULL
at	NULL
2	NULL
h	NULL
whereas	NULL
gliotoxin	NULL
alone	NULL
produced	NULL
almost	NULL
15	NULL
%	NULL
apoptosis	NULL
over	NULL
this	NULL
period	NULL
(	NULL
Figs	NULL
.	NULL

1A	NULL
and	NULL
8B	NULL
)	NULL
.	NULL

While	NULL
gliotoxin	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
cycloheximide	NULL
and	NULL
actinomycin	NULL
D	NULL
have	NULL
been	NULL
shown	NULL
in	NULL
several	NULL
systems	NULL
to	NULL
activate	NULL
this	NULL
transcription	NULL
factor	NULL
(	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Although	NULL
both	NULL
cycloheximide	NULL
and	NULL
gliotoxin	NULL
give	NULL
a	NULL
similar	NULL
synergistic	NULL
pro-apoptotic	NULL
response	NULL
with	NULL
TNF-a	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
different	NULL
mechanisms	NULL
must	NULL
be	NULL
involved	NULL
.	NULL

However	NULL
,	NULL
while	NULL
gliotoxin	NULL
may	NULL
prevent	NULL
synthesis	NULL
of	NULL
a	NULL
protective	NULL
protein	NULL
inducible	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
cycloheximide	NULL
would	NULL
also	NULL
preclude	NULL
synthesis	NULL
of	NULL
such	NULL
a	NULL
protein	NULL
so	NULL
that	NULL
in	NULL
both	NULL
cases	NULL
the	NULL
cells	NULL
would	NULL
be	NULL
sensitive	NULL
to	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
TNF-a	NULL
@	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
granulocytes	NULL
do	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
synthesize	NULL
proteins	NULL
,	NULL
albeit	NULL
in	NULL
a	NULL
limited	NULL
capacity	NULL
(	NULL
49	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
this	NULL
synthetic	NULL
capacity	NULL
will	NULL
be	NULL
directed	NULL
toward	NULL
resolution	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
with	NULL
the	NULL
generation	NULL
of	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
that	NULL
affect	NULL
the	NULL
apoptotic	NULL
program	NULL
of	NULL
inflammatory	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
inducible	NULL
isoform	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
disappears	NULL
from	NULL
the	NULL
gliotoxin-treated	NULL
granulocyte	NULL
nucleus	NULL
just	NULL
before	NULL
the	NULL
onset	NULL
of	NULL
stimulated	NULL
apoptosis	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
these	NULL
events	NULL
are	NULL
causally	NULL
related	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
following	NULL
observations	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
synthetic	NULL
cell-permeable	NULL
peptide	NULL
SN5O	NULL
(	NULL
37	NULL
)	NULL
,	NULL
a	NULL
known	NULL
inhibitor	NULL
of	NULL
NF-kB	NULL
,	NULL
also	NULL
induces	NULL
apoptosis	NULL
in	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
other	NULL
agents	NULL
that	NULL
inhibit	NULL
NF-kB	NULL
activation	NULL
,	NULL
namely	NULL
PDTC	NULL
and	NULL
curcumin	NULL
as	NULL
well	NULL
as	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
MG-132	NULL
also	NULL
cause	NULL
an	NULL
induction	NULL
of	NULL
granulocyte	NULL
apoptosis	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
the	NULL
kinetics	NULL
for	NULL
gliotoxin-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
match	NULL
those	NULL
for	NULL
the	NULL
onset	NULL
of	NULL
induction	NULL
of	NULL
apoptosis	NULL
;	NULL
(	NULL
iv	NULL
)	NULL
LPS	NULL
which	NULL
stimulates	NULL
NF-	NULL
«	NULL
kB	NULL
activity	NULL
prolongs	NULL
neutrophil	NULL
and	NULL
eosinophil	NULL
survival	NULL
;	NULL
and	NULL
(	NULL
v	NULL
)	NULL
that	NULL
gliotoxin	NULL
sensitizes	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
to	NULL
the	NULL
pro-apoptotic	NULL
effects	NULL
of	NULL
TNF-a	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
studies	NULL
provide	NULL
the	NULL
first	NULL
plausible	NULL
explanation	NULL
for	NULL
the	NULL
modest	NULL
and	NULL
temporally	NULL
constrained	NULL
apoptotic	NULL
response	NULL
of	NULL
neutrophils	NULL
to	NULL
TNF-a	NULL
and	NULL
the	NULL
observation	NULL
that	NULL
pretreatment	NULL
with	NULL
LPS	NULL
,	NULL
PAF	NULL
or	NULL
granulocyte/macrophage-colony	NULL
stimulating	NULL
factor	NULL
,	NULL
abolishes	NULL
the	NULL
cytotoxic	NULL
effect	NULL
of	NULL
this	NULL
cytokine	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
latter	NULL
point	NULL
is	NULL
of	NULL
particular	NULL
relevance	NULL
when	NULL
investigating	NULL
the	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
TNF-a	NULL
in	NULL
neutrophils	NULL
since	NULL
pre-treatment	NULL
of	NULL
these	NULL
cells	NULL
causes	NULL
a	NULL
rapid	NULL
decrease	NULL
of	NULL
both	NULL
TNF-a	NULL
receptors	NULL
subtypes	NULL
from	NULL
the	NULL
surface	NULL
membrane	NULL
(	NULL
10	NULL
)	NULL
.	NULL

This	NULL
phenomenon	NULL
,	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
SN50	NULL
are	NULL
,	NULL
at	NULL
best	NULL
,	NULL
modest	NULL
due	NULL
to	NULL
limited	NULL
access	NULL
of	NULL
the	NULL
peptide	NULL
to	NULL
its	NULL
intracellular	NULL
target	NULL
(	NULL
37	NULL
)	NULL
and	NULL
the	NULL
requirement	NULL
for	NULL
pretreatment	NULL
with	NULL
the	NULL
peptide	NULL
,	NULL
precluded	NULL
accurate	NULL
assessment	NULL
of	NULL
SN5O	NULL
on	NULL
TNF-a	NULL
induced	NULL
apoptosis	NULL
in	NULL
neutrophils	NULL
.	NULL

When	NULL
neutrophils	NULL
were	NULL
co-cultured	NULL
with	NULL
LPS	NULL
and	NULL
gliotoxin	NULL
,	NULL
gliotoxin	NULL
failed	NULL
to	NULL
render	NULL
LPS	NULL
pro-apoptotic	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
LPS	NULL
induced	NULL
survival	NULL
was	NULL
inhibited	NULL
by	NULL
gliotoxin	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
LPS	NULL
does	NULL
not	NULL
trigger	NULL
a	NULL
death	NULL
pathway	NULL
in	NULL
neutrophils	NULL
but	NULL
stimulates	NULL
a	NULL
NF-	NULL
«	NULL
B-mediated	NULL
survival	NULL
pathway	NULL
i.e	NULL
.	NULL

when	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
blocked	NULL
,	NULL
LPS	NULL
is	NULL
no	NULL
longer	NULL
capable	NULL
of	NULL
delaying	NULL
apoptosis	NULL
.	NULL

The	NULL
precise	NULL
intracellular	NULL
mechanisms	NULL
by	NULL
which	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
used	NULL
in	NULL
this	NULL
study	NULL
induce	NULL
apoptosis	NULL
are	NULL
unknown	NULL
and	NULL
is	NULL
the	NULL
subject	NULL
of	NULL
further	NULL
investigation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
it	NULL
would	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
perform	NULL
an	NULL
in-depth	NULL
analyses	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
gliotoxin	NULL
and	NULL
the	NULL
other	NULL
4317	NULL
agents	NULL
on	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
inhibitory	NULL
subunit	NULL
IB	NULL
,	NULL
especially	NULL
since	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

(	NULL
28	NULL
)	NULL
reported	NULL
that	NULL
gliotoxin	NULL
appeared	NULL
to	NULL
prevent	NULL
I	NULL
«	NULL
B	NULL
degradation	NULL
rather	NULL
than	NULL
mediate	NULL
its	NULL
effect	NULL
at	NULL
the	NULL
level	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
immune	NULL
cells	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
agents	NULL
such	NULL
as	NULL
TNF-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
genes	NULL
for	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
granulo-cyte/macrophage-colony	NULL
stimulating	NULL
factor	NULL
and	NULL
TNF-	NULL
«	NULL
@	NULL
itself	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
this	NULL
response	NULL
in	NULL
vivo	NULL
is	NULL
that	NULL
many	NULL
of	NULL
these	NULL
factors	NULL
inhibit	NULL
granulocyte	NULL
apoptosis	NULL
and	NULL
may	NULL
therefore	NULL
delay	NULL
inflammatory	NULL
resolution	NULL
by	NULL
enhancing	NULL
the	NULL
longevity	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
positive-feedback	NULL
loop	NULL
may	NULL
exist	NULL
since	NULL
many	NULL
of	NULL
these	NULL
inflammatory	NULL
mediators	NULL
which	NULL
protect	NULL
against	NULL
apoptosis	NULL
in	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
also	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
NO	NULL
,	NULL
a	NULL
known	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
,	NULL
is	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
apoptosis	NULL
in	NULL
neutrophils	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Our	NULL
current	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
represents	NULL
a	NULL
powerful	NULL
survival	NULL
mechanism	NULL
in	NULL
granulocytes	NULL
,	NULL
and	NULL
that	NULL
when	NULL
this	NULL
pathway	NULL
is	NULL
inhibited	NULL
,	NULL
in	NULL
both	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
,	NULL
these	NULL
cells	NULL
undergo	NULL
a	NULL
greatly	NULL
augmented	NULL
rate	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
performs	NULL
a	NULL
similar	NULL
function	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
that	NULL
undergo	NULL
apoptosis	NULL
in	NULL
response	NULL
to	NULL
gliotoxin	NULL
.	NULL

Enhanced	NULL
cytotoxic	NULL
responses	NULL
to	NULL
TNF-a	NULL
have	NULL
also	NULL
been	NULL
demonstrated	NULL
in	NULL
cells	NULL
where	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
genetically	NULL
deficient	NULL
or	NULL
inac-tivated	NULL
(	NULL
19-21	NULL
)	NULL
and	NULL
hepatocytes	NULL
from	NULL
Rel-A	NULL
null	NULL
mice	NULL
are	NULL
known	NULL
to	NULL
undergo	NULL
apoptosis	NULL
causing	NULL
death	NULL
in	NULL
utero	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Embryonic	NULL
fibroblasts	NULL
and	NULL
macrophages	NULL
from	NULL
Rel-A-deficient	NULL
mice	NULL
also	NULL
showed	NULL
dramatic	NULL
loss	NULL
of	NULL
viability	NULL
when	NULL
treated	NULL
with	NULL
TNF-a	NULL
leading	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
Rel-A	NULL
regulates	NULL
a	NULL
protective	NULL
mechanism	NULL
against	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-a	NULL
.	NULL

It	NULL
would	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
TNF-a	NULL
and	NULL
gliotoxin	NULL
on	NULL
granulocytes	NULL
isolated	NULL
from	NULL
mice	NULL
deficient	NULL
in	NULL
Rel	NULL
A	NULL
;	NULL
it	NULL
would	NULL
be	NULL
reasonable	NULL
to	NULL
predict	NULL
that	NULL
TNF-a	NULL
will	NULL
induce	NULL
a	NULL
rapid	NULL
cell	NULL
death	NULL
and	NULL
gliotoxin	NULL
and	NULL
other	NULL
NF-	NULL
«	NULL
B	NULL
inhibitors	NULL
would	NULL
not	NULL
have	NULL
a	NULL
dramatic	NULL
effect	NULL
on	NULL
the	NULL
rate	NULL
of	NULL
granulocyte	NULL
apoptosis	NULL
.	NULL

Although	NULL
our	NULL
experiments	NULL
indicate	NULL
that	NULL
gliotoxin	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
constitutive	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
at	NULL
least	NULL
at	NULL
early	NULL
time	NULL
points	NULL
,	NULL
it	NULL
does	NULL
inhibit	NULL
the	NULL
activation	NULL
of	NULL
an	NULL
inducible	NULL
isoform	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
which	NULL
most	NULL
likely	NULL
consists	NULL
of	NULL
heterodimers	NULL
containing	NULL
the	NULL
Rel-A/p65	NULL
protein	NULL
and	NULL
therefore	NULL
could	NULL
perform	NULL
a	NULL
similar	NULL
anti-apoptotic	NULL
function	NULL
in	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
.	NULL

While	NULL
in	NULL
our	NULL
hands	NULL
TNF-a	NULL
does	NULL
not	NULL
produce	NULL
significant	NULL
cytotoxic	NULL
effects	NULL
in	NULL
eosinophils	NULL
,	NULL
co-treatment	NULL
with	NULL
gliotoxin	NULL
caused	NULL
these	NULL
cells	NULL
to	NULL
become	NULL
highly	NULL
responsive	NULL
to	NULL
this	NULL
cytokine	NULL
producing	NULL
greatly	NULL
increased	NULL
levels	NULL
of	NULL
apoptosis	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
both	NULL
of	NULL
these	NULL
inflammatory	NULL
cell	NULL
types	NULL
could	NULL
be	NULL
stimulated	NULL
to	NULL
undergo	NULL
apoptosis	NULL
and	NULL
hence	NULL
be	NULL
cleared	NULL
rapidly	NULL
by	NULL
phagocytes	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
if	NULL
activation	NULL
of	NULL
the	NULL
inducible	NULL
NF-kB	NULL
isoform	NULL
were	NULL
inhibited	NULL
.	NULL

The	NULL
mechanism	NULL
whereby	NULL
inactivation	NULL
of	NULL
NF-kB	NULL
induces	NULL
granulocyte	NULL
apoptosis	NULL
and	NULL
increases	NULL
the	NULL
cytotoxic	NULL
response	NULL
to	NULL
TNF-a	NULL
is	NULL
currently	NULL
unclear	NULL
.	NULL

Since	NULL
gliotoxin	NULL
and	NULL
TNF-	NULL
«	NULL
driven	NULL
apoptosis	NULL
are	NULL
both	NULL
inhibited	NULL
by	NULL
the	NULL
caspase-inhibitor	NULL
zVAD-fmk	NULL
,	NULL
this	NULL
,	NULL
together	NULL
with	NULL
the	NULL
synergy	NULL
for	NULL
apoptosis	NULL
observed	NULL
with	NULL
these	NULL
agents	NULL
,	NULL
implies	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
regulated	NULL
step	NULL
influences	NULL
granulocyte	NULL
apoptosis	NULL
at	NULL
an	NULL
intermediate	NULL
step	NULL
between	NULL
the	NULL
TNF-a	NULL
receptor	NULL
and	NULL
caspase	NULL
activation	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
controls	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
a	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
which	NULL
induces	NULL
the	NULL
synthesis	NULL
of	NULL
survival	NULL
proteins	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
cycloheximide	NULL
also	NULL
increases	NULL
apoptosis	NULL
in	NULL
granulocytes	NULL
(	NULL
49	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
strong	NULL
link	NULL
between	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
the	NULL
control	NULL
of	NULL
TNF-a	NULL
«	NULL
-induced	NULL
apoptosis	NULL
,	NULL
possibly	NULL
via	NULL
the	NULL
production	NULL
of	NULL
a	NULL
protein	NULL
inhibitor	NULL
of	NULL
this	NULL
pathway	NULL
.	NULL

Indeed	NULL
,	NULL
as	NULL
we	NULL
have	NULL
shown	NULL
,	NULL
protein	NULL
synthesis	NULL
inhibition	NULL
enhances	NULL
the	NULL
pro-apoptotic	NULL
effect	NULL
of	NULL
TNF-a	NULL
as	NULL
early	NULL
as	NULL
2	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Indeed	NULL
,	NULL
one	NULL
possible	NULL
candidate	NULL
for	NULL
this	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
4318	NULL
protein	NULL
has	NULL
already	NULL
been	NULL
suggested	NULL
:	NULL
A20	NULL
,	NULL
a	NULL
protein	NULL
induced	NULL
by	NULL
TNF	NULL
-a	NULL
«	NULL
activation	NULL
of	NULL
NF-kB	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
protect	NULL
against	NULL
TNF	NULL
induced	NULL
cell	NULL
death	NULL
by	NULL
acting	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
proteins	NULL
TRAF-1	NULL
and	NULL
TRAF2	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Although	NULL
A20	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
demonstrated	NULL
in	NULL
neutrophils	NULL
or	NULL
eosinophils	NULL
,	NULL
this	NULL
would	NULL
represent	NULL
an	NULL
attractive	NULL
candidate	NULL
protein	NULL
to	NULL
fulfill	NULL
such	NULL
a	NULL
role	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
gliotoxin	NULL
to	NULL
enhance	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
TNF-a	NULL
and	NULL
itself	NULL
produce	NULL
a	NULL
rapid	NULL
onset	NULL
of	NULL
apoptosis	NULL
in	NULL
inflammatory	NULL
cells	NULL
such	NULL
as	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
may	NULL
suggest	NULL
NF-	NULL
«	NULL
B	NULL
inhibition	NULL
as	NULL
a	NULL
logical	NULL
therapeutic	NULL
target	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
inflammatory	NULL
conditions	NULL
.	NULL

In	NULL
a	NULL
rat	NULL
model	NULL
of	NULL
lung	NULL
inflammation	NULL
,	NULL
suppression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
has	NULL
already	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
the	NULL
development	NULL
of	NULL
neutrophil	NULL
lung	NULL
inflammation	NULL
by	NULL
inhibiting	NULL
the	NULL
synthesis	NULL
of	NULL
chemotaxins	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
inhibition	NULL
may	NULL
also	NULL
be	NULL
of	NULL
benefit	NULL
in	NULL
enhancing	NULL
the	NULL
resolution	NULL
of	NULL
inflammation	NULL
by	NULL
allowing	NULL
a	NULL
more	NULL
rapid	NULL
clearance	NULL
of	NULL
granulocytes	NULL
.	NULL

We	NULL
therefore	NULL
propose	NULL
that	NULL
granulocyte	NULL
apoptosis	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
form	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
suggest	NULL
that	NULL
inhibition	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
may	NULL
be	NULL
exploited	NULL
for	NULL
therapeutic	NULL
benefit	NULL
in	NULL
inflammatory	NULL
conditions	NULL
where	NULL
granulocytes	NULL
play	NULL
a	NULL
prominent	NULL
role	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Savill	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Wyllie	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Henson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Walport	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Henson	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
865-875	NULL
2	NULL
.	NULL

Stern	NULL
,	NULL
M.	NULL
,	NULL
Meagher	NULL
,	NULL
L.	NULL
,	NULL
Savill	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3548-3549	NULL
3	NULL
.	NULL

Whyte	NULL
,	NULL
M.	NULL
K.	NULL
B.	NULL
,	NULL
Meagher	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
MacDermot	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
5124-5134	NULL
4	NULL
.	NULL

Stern	NULL
,	NULL
M.	NULL
,	NULL
Savill	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

149	NULL
,	NULL
911-921	NULL
5	NULL
.	NULL

Her	NULL
,	NULL
E.	NULL
,	NULL
Frazer	NULL
,	NULL
J.	NULL
,	NULL
Austen	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
1982-1987	NULL
6	NULL
.	NULL

Colotta	NULL
,	NULL
F.	NULL
,	NULL
Re	NULL
,	NULL
F.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
,	NULL
Sozzani	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
2012-2020	NULL
.	NULL

Lee	NULL
,	NULL
A.	NULL
,	NULL
Whyte	NULL
,	NULL
M.	NULL
K.	NULL
B.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

54	NULL
,	NULL
283-288	NULL
.	NULL

Takanaski	NULL
,	NULL
S.	NULL
,	NULL
Nonaka	NULL
,	NULL
R	NULL
,	NULL
Xing	NULL
,	NULL
X.	NULL
,	NULL
O'Byrne	NULL
,	NULL
P.	NULL
,	NULL
Dolovich	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Jordanna	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180	NULL
,	NULL
711-715	NULL
9	NULL
.	NULL

Meagher	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Cousin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Seckl	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
4422-4428	NULL
10	NULL
.	NULL

Murray	NULL
,	NULL
J.	NULL
,	NULL
Barbara	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
J.	NULL
,	NULL
Dunkley	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Lopez	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
Van	NULL
Ostade	NULL
,	NULL
X.	NULL
,	NULL
Condliffe	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Dransfield	NULL
,	NULL
L.	NULL
,	NULL
Haslett	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chilvers	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
2772-2783	NULL
11	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
182-185	NULL
12	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
5488-5441	NULL
13	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
11884-11888	NULL
14	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baichwal	NULL
,	NULL
V.	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

62	NULL
,	NULL
1192-1198	NULL
15	NULL
.	NULL

May	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
19	NULL
,	NULL
80-88	NULL
16	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
,	NULL
Jr.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
649-681	NULL
17	NULL
.	NULL

Wu	NULL
,	NULL
M.	NULL
,	NULL
Lee	NULL
,	NULL
H.	NULL
,	NULL
Bellas	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Schauer	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Arsura	NULL
,	NULL
M.	NULL
,	NULL
Katz	NULL
,	NULL
D.	NULL
,	NULL
FitzGerald	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Rothstein	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Sherr	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
and	NULL
Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
4682-4690	NULL
18	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
Bauer	NULL
,	NULL
M.	NULL
K.	NULL
A.	NULL
,	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

184	NULL
,	NULL
18-28	NULL
19	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
782-784	NULL
20	NULL
.	NULL

Van	NULL
Antwerp	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Martin	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Kafri	NULL
,	NULL
T.	NULL
,	NULL
Green	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
787-789	NULL
go	NULL
i	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32.	NULL
.	NULL

Rossi	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Cousin	NULL
J.	NULL
M.	NULL
,	NULL
Dransfield	NULL
I.	NULL
,	NULL
Lawson	NULL
M.	NULL
F.	NULL
,	NULL
Chilvers	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
.	NULL

Singh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Aggarwal	NULL
,	NULL
B	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
.	NULL

270	NULL
,	NULL
24995-25000	NULL
40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

NF-kB	NULL
and	NULL
Granulocyte	NULL
Apoptosis	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
,	NULL
Mayo	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
784-787	NULL
.	NULL

McDonald	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Bald	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Cassatella	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Blood	NULL
89	NULL
,	NULL
3421-8433	NULL
.	NULL

Browning	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Pan	NULL
,	NULL
Z.	NULL
K.	NULL
,	NULL
Prossnitz	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
and	NULL
Ye	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
7995-8001	NULL
.	NULL

Braithwaite	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Eichner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Waring	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Miillbacher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Immunol	NULL
.	NULL

24	NULL
,	NULL
47-55	NULL
Ozaki	NULL
,	NULL
K.	NULL
,	NULL
Takeda	NULL
,	NULL
H.	NULL
,	NULL
Iwahashi	NULL
,	NULL
H.	NULL
,	NULL
Kitano	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hanazawa	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

410	NULL
,	NULL
297-300	NULL
Waring	NULL
,	NULL
P.	NULL
,	NULL
Eichner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
Miillbacher	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Sjaarda	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
18493-18499	NULL
Sutton	NULL
,	NULL
P.	NULL
,	NULL
Newcombe	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
Waring	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Miillbacher	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Infect	NULL
.	NULL

Immunol	NULL
.	NULL

62	NULL
,	NULL
1192-1198	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
KrauB	NULL
,	NULL
B.	NULL
,	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
,	NULL
Decker	NULL
,	NULL
T.	NULL
,	NULL
Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
Vogt	NULL
,	NULL
M.	NULL
,	NULL
Myers	NULL
,	NULL
C.	NULL
,	NULL
Parks	NULL
,	NULL
T.	NULL
,	NULL
Warring	NULL
,	NULL
P.	NULL
,	NULL
Miihlbacher	NULL
,	NULL
A.	NULL
,	NULL
Czernilofsky	NULL
,	NULL
A-P.	NULL
,	NULL
and	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1829-1840	NULL
Haslett	NULL
,	NULL
C.	NULL
,	NULL
Guthrie	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Kopaniak	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Johnston	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Henson	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

119	NULL
,	NULL
101-110	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Whyte	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Hardwick	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Meagher	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Savill	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
19938	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92	NULL
,	NULL
446-455	NULL
Cousin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Haslett	NULL
C.	NULL
,	NULL
and	NULL
Rossi	NULL
A.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

25	NULL
,	NULL
2438	NULL
Haslett	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

271	NULL
,	NULL
892-899	NULL
Hannah	NULL
,	NULL
S.	NULL
,	NULL
Mecklenburgh	NULL
,	NULL
K.	NULL
,	NULL
Rahman	NULL
,	NULL
I.	NULL
,	NULL
Bellingan	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Greening	NULL
,	NULL
A.	NULL
,	NULL
Haslett	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Chilvers	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

872	NULL
,	NULL
283-237	NULL
Hachiya	NULL
,	NULL
O.	NULL
,	NULL
Takeda	NULL
,	NULL
Y.	NULL
,	NULL
Miyata	NULL
,	NULL
H.	NULL
,	NULL
Watanabe	NULL
,	NULL
H.	NULL
,	NULL
Yamashita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sendo	NULL
,	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

89	NULL
,	NULL
715-723	NULL
Ward	NULL
,	NULL
C.	NULL
,	NULL
Murray	NULL
,	NULL
J.	NULL
,	NULL
Bruce	NULL
,	NULL
L.	NULL
,	NULL
Farrow	NULL
,	NULL
S.	NULL
,	NULL
Chilvers	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Hannah	NULL
,	NULL
S.	NULL
,	NULL
Haslett	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Rossi	NULL
,	NULL
A.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

25	NULL
,	NULL
2458	NULL
Lin	NULL
,	NULL
Y.	NULL
,	NULL
Yao	NULL
,	NULL
S.	NULL
,	NULL
Veach	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Torgerson	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
14255-14258	NULL
Adams	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Stein	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rep.	NULL
Med	NULL
.	NULL

Chem	NULL
.	NULL

81	NULL
,	NULL
279-287	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Mannel	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
1181-1194	NULL
Druker	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Neumann	NULL
,	NULL
M.	NULL
,	NULL
Okuda	NULL
,	NULL
K.	NULL
,	NULL
Franza	NULL
,	NULL
B.	NULL
R	NULL
,	NULL
and	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
5887-5890	NULL
MacDonald	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
and	NULL
Cassatella	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

412	NULL
,	NULL
583-586	NULL
Vollebregt	NULL
,	NULL
M.	NULL
,	NULL
Hampton	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Winterbourn	NULL
,	NULL
C.	NULL
C.	NULL
(	NULL
1998	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

432	NULL
,	NULL
40-44	NULL
.	NULL

Lui	NULL
,	NULL
Z.	NULL
,	NULL
Hsu	NULL
,	NULL
H.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
565-576	NULL
45	NULL
.	NULL

Sutton	NULL
,	NULL
P.	NULL
,	NULL
Beaver	NULL
J.	NULL
,	NULL
and	NULL
Waring	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
.	NULL

50	NULL
,	NULL
2009-2014	NULL
Hallsworth	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Giembycz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Barnes	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
T.	NULL
H.	NULL
(	NULL
1996	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Pharmacol	NULL
.	NULL

117	NULL
,	NULL
79-86	NULL
Waring	NULL
,	NULL
P.	NULL
,	NULL
Khan	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Sjaarda	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
17929-17986	NULL
Waring	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
14476-14480	NULL
Whyte	NULL
,	NULL
M.	NULL
K.	NULL
B.	NULL
,	NULL
Savill	NULL
,	NULL
J.	NULL
,	NULL
Meagher	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Lee	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

62	NULL
,	NULL
195-202	NULL
Newton	NULL
,	NULL
R.	NULL
,	NULL
Adcock	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Barnes	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Biochem	NULL
.	NULL

Biophy	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

218	NULL
,	NULL
518-528	NULL
Faggioli	NULL
,	NULL
L.	NULL
,	NULL
Costanzo	NULL
,	NULL
C.	NULL
,	NULL
Merola	NULL
,	NULL
M.	NULL
,	NULL
Furia	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Palmieri	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Biochem	NULL
.	NULL

Biophy	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

288	NULL
,	NULL
507-518	NULL
Matthews	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Botting	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Panico	NULL
,	NULL
M.	NULL
,	NULL
Morris	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
and	NULL
Hay	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

24	NULL
,	NULL
2286-2242	NULL
.	NULL

Peng	NULL
,	NULL
H.	NULL
,	NULL
Libby	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Liao	NULL
,	NULL
J.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
14214-14219	NULL
.	NULL

Wong	NULL
,	NULL
T.	NULL
,	NULL
Rossi	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
and	NULL
Chilvers	NULL
,	NULL
E.	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Sci	NULL
.	NULL

92	NULL
,	NULL
7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Sha	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Bronson	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
876	NULL
,	NULL
167-170	NULL
Krikos	NULL
,	NULL
A.	NULL
,	NULL
Lahberty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
17971-17976	NULL
Opipari	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Hu	NULL
.	NULL

,	NULL
H.	NULL
M.	NULL
,	NULL
Yabkowitz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
12424-12427	NULL
Song	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
(	NULL
1996	NULL
)	NULL
Biochemistry	NULL
98	NULL
,	NULL
6721-6725	NULL
Blackwell	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Blackwell	NULL
,	NULL
T.	NULL
,	NULL
Holden	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Christman	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
and	NULL
Christman	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
1630-1678	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
NF-KB	NULL
Activation	NULL
Is	NULL
a	NULL
Critical	NULL
Regulator	NULL
of	NULL
Human	NULL
Granulocyte	NULL
Apoptosis	NULL
in	NULL
Vitro	NULL
Carol	NULL
Ward	NULL
,	NULL
Edwin	NULL
R.	NULL
Chilvers	NULL
,	NULL
Mark	NULL
F.	NULL
Lawson	NULL
,	NULL
James	NULL
G.	NULL
Pryde	NULL
,	NULL
Satoko	NULL
Fujihara	NULL
,	NULL
Stuart	NULL
N.	NULL
Farrow	NULL
,	NULL
Christopher	NULL
Haslett	NULL
and	NULL
Adriano	NULL
G.	NULL
Rossi	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:4309-4318.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.7.4309	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/7/4309	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
references	NULL
,	NULL
28	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

